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SUMMARY
All eukaryotic cells have transport pathways to constitutively secrete proteins. Endocrine,
neuroendocrine, and exocrine cells in addition have a regulated secretory pathway that
serves the controlled release of hormones, neuropeptides or digestive enzymes. In the trans-
Golgi network (TGN) precursors of regulated secretory proteins are segregated and
packaged in a concentrated form in secretory granules where they are processed and
activated before release in response to an extracellular stimulus by fusion with the plasma
membrane. Little is known about the machinery involved in the generation of secretory
granules. The current models propose that luminal proteins interact with transmembrane
receptors and/or that cargo proteins form insoluble aggregates due to milieu acidification
resulting in membrane association and formation of a secretory granule.
We discovered that even in non-endocrine cells the expression of regulated cargo proteins is
sufficient to induce granule-like structures. We showed that cargo proteins accumulate in the
TGN where they are sorted into membrane vesicles. These structures did not colocalize with
organelle markers for the endoplasmic reticulum, the Golgi, the TGN, lysosomes, and
endosomes. The helper cargo proteins secretogranin II and chromogranin B were stored
intracellularly, and their secretion could be stimulated by addition of a calcium ionophore.
Considerable differences were observed in efficiency of induction and in morphology of
granule-like structures depending on the expressed cargo protein. Granins were more
efficient, capable to sort other cargo proteins, and modulate the size of granule-like
structures. Some accessory proteins such as the proprotein convertases PC3 and PC6A but
also the IP3-R/Ca2+ channel sorted into granule-like structures when coexpressed with
secretogranin II. The data suggest that secretory granule formation is a self-assembly process
which is optimized by an endocrine-specific machinery.
Carboxypeptidase E was proposed to function as a sorting receptor with an unconventional
transmembrane anchor similar to PC2 and PC3. The topology of theses proteins is
particularly important for granule sorting and association with putative interaction partners.
A systematic analysis showed that PC3 is a luminal protein suggesting that granule targeting
of PCs and CPE is not achieved by direct interaction with cytosolic proteins.
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ABBREVIATIONS
A1Pi α1-protease inhibitor
A1PiTS Tyrosine sulfation-tagged A1Pi
ACTH Adrenocorticotropic hormone
ADP Adenosine diphosphate
AP-1 Adaptor protein 1
APP Amyloid precursor protein
ARF1 ADP-ribosylation factor 1
ATP Adenosine triphosphate
BACE β-site APP cleaving enzyme
BSA Bovine serum albumin
CCV Clathrin coated vesicle
CgA Chromogranin A
CgB Chromogranin B
CHO Chinese hamster ovary
CK2 Casein kinase II
COP Coat protein complex
CPE Carboxypeptidase E
CSP Constitutive secretory pathway
EE Early endosomes
EEA1 Early endosome antigen 1
EM Electron microscopy
Endo H Endoglycosidase H
ER Endoplasmic reticulum
F-actin Filamentous actin
Fig Figure
GAP GTPase activating protein
GEF Guanine nucleotide exchange factor
GFP Green fluorescent protein
GTP Guanosine triphosphate
HEK Human embryonic kidney
HEPES N-2-Hydroxyethylpiperazine-N'-2-ethane-sulfonic acid
IF Immunofluorescence
IP Immunoprecipitation
IP3-R Inositol 1,4,5-trisphosphate receptor
ISG Immature secretory granule
Lamp-1 Lysosome-associated membrane protein 1
M6P Mannose-6-phosphate
MPR Mannose-6-phosphate receptor
NPII Neurophysin II
PACS-1 Phosphofurin acidic cluster-sorting protein
12
PBS Phosphate-buffered saline
PC Proprotein convertase
PCR Polymerase chain reaction
POMC Pro-opiomelanocortin
PP2A Protein phosphatase 2A
RSP Regulated secretory pathway
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis
SgII Secretogranin II
SG Secretory granule
SNARE Soluble N-ethylmaleimide-sensitive factor attachment protein receptor
SNX Sorting nexin
SRP Signal recognition particle
SP Signal peptide
SPC Subtilisin-like proprotein convertase
TGF-β Transforming growth factor β
TM Transmembrane
TGN Trans Golgi network
VAMP Vesicle associated membrane protein
Vaso Pro-vasopressin
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INTRODUCTION
1. Membrane Traffic
Eukaryotic cells are structured into various compartments or organelles with characteristic
functions. These compartments include the endoplasmic reticulum (ER), the Golgi appara-
tus, endosomes, lysosomes, mitochondria, chloroplasts, peroxisomes, a nucleus and the
cytosol. Proteins are synthesized on ribosomes and follow defined transport pathways to
reach the compartment of their function. The vast majority of proteins destined to intracel-
lular compartments, the plasma membrane or the cell exterior use the translocation route
across or into the ER membrane.
The ER consists of a continuous network of membrane tubules and sacs that extend netlike
from the nucleus throughout the cytosol of eukaryotic cells. The ER membranes separate the
cytosol from the exoplasmic ER lumen and permit selective transfer of proteins between
these two compartments. The ER plays a central role in protein and lipid synthesis. Soluble
and transmembrane proteins destined to the ER, Golgi, endosomes, lysosomes, secretory
granules, secretory vesicles, and the plasma membrane are initially delivered to the ER
lumen.
Integration of membrane proteins into the ER occurs via the Sec61 pore complex. Membrane
targeting is achieved via a hydrophobic signal peptide in the primary sequence of nascent
proteins (von Heijne, 1990). Upon interaction of the signal peptide with the signal recogni-
tion particle (SRP) and its subsequent interaction with the SRP-receptor, the ribosome is
docked to the translocon (Keenan et al., 2001). The signal peptide then enters the tunnel, and
the nascent polypeptide chain is synthesized into the ER lumen. Polypeptides fold into their
three-dimensional conformation and associate with other subunits assisted by chaperones.
Translocated segments of proteins can undergo further modifications such as N-linked
glycosylation and disulfide bond formation in the ER lumen. In addition, the ER also serves
for synthesis of phospholipids, cholesterol and ceramides.
Misfolded proteins cannot exit the ER and are eliminated via ER-associated protein degra-
dation (ERAD) (Meusser et al., 2005). A quality control system within the ER activates the
ERAD pathway resulting in dislocation of unfolded proteins and their subsequent degrada-
tion by the cytosolic ubiquitin-proteasome system (Nandi et al., 2006). Proteins that meet
quality control standards can leave the ER at ribosome-free ER-exit sites for anterograde
transport passing trough the ER-Golgi intermediate compartment (ERGIC) towards the
Golgi (Fig. 1).
The ERGIC is a tubulovesicular membrane cluster which serves as sorting station for
anterograde and retrograde traffic (Appenzeller-Herzog and Hauri, 2006). ERGIC mem-
branes receive cargo proteins from ER-exit sites, recycle ER proteins and deliver secretory
cargo to the cis-Golgi (Warren and Mellman, 1999).
The Golgi complex is composed of a stack of flattened membrane-enclosed sacs. Proteins
enter the complex from the cis-side and are transported through the different compartments
towards the trans-side. During transport resident proteins sequentially modify N-linked
Introduction 14
carbohydrate side-chains to a complex form and add O-linked oligosaccharides. On the
trans-side the Golgi is connected to a tubulovesicular structure referred to as trans-Golgi
network (TGN). It is the site of sialylation and sulfation modifications and serves as the cell's
main sorting and distribution center. The different types of proteins are sorted and shipped
to their final destination. Some are destined for the cell exterior and the plasma membrane
while others are transported to intracellular compartments such as endosomes or lysosomes.
These sorting processes are crucial for the cell as, for instance, lysosomal enzymes have
potential destructive effects and therefore need to be sequestered from the remaining
constituents. In addition, the Golgi functions in lipid metabolism notably the synthesis of
glycolipids and sphingomyelins.
The endocytic pathway serves for uptake of macromolecules from the cell exterior. Mem-
brane receptors and ligands are taken up by the plasma membrane and transported inward
to endosomes, the Golgi and the ER. These transport steps are referred to as retrograde
transport. Endocytosed material is initially delivered to endosomes which constitute a major
sorting compartment for redistribution to late endosomes, TGN and plasma membrane.
Ligand-receptor complexes dissociate due to the reduced pH in endosomes, ligands are
delivered to late endosomes and lysosomes for degradation and downregulation of signaling
events while receptors are recycled back to the plasma membrane.
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2. Transport Vesicles
In eukaryotic cells, proteins and membranes are transported along the exocytic and endo-
cytic pathways (Fig. 1) in a strictly controlled and selective manner. Intracellular trafficking
is classically mediated by membrane vesicles that vary in size and form from small spherical
to larger irregular packages. Transport vesicles mediate the passage of membrane compo-
nents and soluble molecules from a donor compartment to a target compartment. The
molecular mechanisms that control vesicle packaging, budding and fusion have been studied
extensively.
FIG. 1.  Illustration of the major membrane traffic pathways using carrier vesicles coated with
COPI, COPII, and clathrin (Bonifacino and Glick, 2004).
2.1 Coats and Signals
The formation of vesicles requires cytosolic coat proteins that are responsible for cargo
protein selection and vesicle budding. Cargo selection is achieved by sorting signals that lie
in the primary sequence of cargo proteins. Most transport steps rely on one of the character-
istic coatomers coat protein I (COPI), COPII or clathrin and its partners (Kirchhausen, 2000).
COPI vesicles are involved in retrograde traffic from Golgi to ER and in intra-Golgi trans-
port. COPII vesicles mediate anterograde traffic from ER to Golgi. The multiple trafficking
routes for clathrin-coated-vesicles (CCVs) are from the Golgi to early endosomes, from the
plasma membrane to early endosomes and recycling from early endosomes back to the
plasma membrane as well as from early endosomes to the Golgi.
2.1.1 COPI Vesicles
The formation of COPI vesicles starts with the activation of the GTP-binding protein ARF1
(ADP-ribosylation factor 1) by a corresponding guanine nucleotide exchange factors (GEF) at
the Golgi membrane. In the active GTP-bound state ARF1 becomes membrane bound via its
myristoyl tail which allows subsequent binding of COPI coat proteins. Cargo proteins
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containing the dilysine sorting signal K(X)KXX (Cosson et al., 1991) are either bound directly
or via the transmembrane KDEL-receptor that in turn binds luminal proteins with a
C-terminal KDEL sorting sequence. During coat recruitment the membrane deforms, and
when the coat is complete, the vesicle buds off. The carrier vesicle is uncoated in response to
ARF1 GTP hydrolysis activated by the GTPase activating protein (GAP) ARFGAP1
(Goldberg, 1999) leading to inactivation of ARF1 and uncoating.
2.1.2 COPII Vesicles
Newly synthesized secretory proteins are sorted into COPII-coated vesicles at ribosome-free
ER exit sites. COPII vesicles are initiated by membrane recruitment of the cytosolic GTPase
Sar1p-GDP upon interaction with the membrane bound GEF Sec12p (Barlowe and Schek-
man, 1993). Sar1p-GTP then allows the association with the Sec23p-Sec24p complex and
cargo proteins/adaptors bearing diphenylalanine or diacidic motifs. In the following step,
the scaffolding complex Sec13p-Sec31p binds and deforms the membrane to build a vesicle
(Barlowe et al., 1994). GTP hydrolysis of Sar1p activated by the GAP Sec23p leads to uncoat-
ing before membrane fusion with a target membrane can occur.
2.1.3 Clathrin Coated Vesicles
Clathrin triskelia build a basket-like scaffold that promotes membrane deformation and
vesicle budding. For recruitment of clathrin to membranes there exist various adaptors such
as the heterotetrameric adaptor proteins (AP-1, AP-2, AP-3, AP-4) or monomeric Golgi-
localized γ-ear-containing ADP-ribosylation binding factor protein (GGA) for example. The
coat protein clathrin is assembled on adaptor proteins distorting the membranes to form a
carrier vesicle. The general sorting sequences for clathrin coated vesicles (CCVs) are tyrosine-
based YXXΦ and dileucine motifs in the cytosolic tails of membrane cargo proteins. The
recruitment of clathrin is nucleotide dependent. ARF1 is involved in the recruitment of AP-1
to TGN membranes (Stamnes and Rothman, 1993; Traub et al., 1993) but not in uncoating as
it is the case for COPI. The minimal machinery to form CCVs at the TGN consists of myris-
toylated ARF1, GTP, tyrosine-based sorting signals, specific phosphoinositides, AP-1 and
clathrin (Zhu et al., 1998; Zhu et al., 1999). Alternatively, AP-1 was recruited to liposomes in
the absence of sorting signals in an ARF1- and cytosol-dependent manner, suggesting the
involvement of a cytosolic factor functioning in AP-1 docking (Crottet et al., 2002). AP-1-
dependent CCVs further mediate transport from endosomes to the TGN and recycling of
receptors to the plasma membrane (Pagano et al., 2004). In a similar way, AP-2 mediates CCV
formation at the plasma membrane to permit receptor-mediated endocytosis (Nakatsu and
Ohno, 2003) or the internalization of previously exocytosed synaptic vesicles membrane
proteins and lipids (Slepnev and De Camilli, 2000). AP-3 was proposed to function in the
formation of synaptic vesicles from endosomes of neuroendocrine cells (Faundez et al., 1998).
AP-3 and ARF1 were sufficient to reconstitute synaptic vesicle formation from endosomes
dependent on ATP and temperature. AP-3 also mediates the delivery of transmembrane
glycoproteins from the TGN to lysosomes (Le Borgne et al., 1998). Clathrin disassembly is
regulated by the heat shock protein Hsc70 and auxilin in an ATP-dependent manner
Introduction 17
(Ungewickell et al., 1995). In addition, various accessory proteins are involved in CCV
formation to ensure regulation of the multiple clathrin-dependent sorting events each
requiring a specific set of adaptors and regulators. Specific accessory factors involved in
cargo selection, interaction with the actin cytoskeleton, vesicle scission and uncoating were
reviewed by Lafer (2002).
The mannose-6-phosphate receptor (MPR) is used here as an example to describe the various
trafficking routes mediated by CCVs. MPR follows a well-studied trafficking itinerary
between Golgi, endosomes and plasma membrane (Fig. 2). The 46 kDa cation-dependent
MPR (CD-MPR) and the 300 kDa cation-independent MPR (CI-MPR) share the task of
delivering newly synthesized acid hydrolases from the TGN to lysosomes (Kornfeld, 1986;
Ghosh et al., 2003). The mannose-6-phosphate modification of an N-linked carbohydrate
chain is the sorting signal required for interaction with the MPR. The cytoplasmic domain of
the receptor contains a sorting signal for AP-1 and/or GGA binding for subsequent packag-
ing into CCVs destined to early endosomes. During maturation of early to late endosomes,
hydrolases are released from the receptor due to acidification of the milieu and delivered to
lysosomes via organelle fusion. MPRs do not enter the lysosomal compartment and are
recycled form late endosomes back to the TGN regulated by tail-interacting protein of 47
kDa (TIP47) and the GTPase Rab9. Recycling of the CI-MPR from early endosomes to TGN is
mediated by PACS-1 and AP1. The CI-MPR is also involved in binding insulin-like growth
factor-II (IGF-II) at the cell surface for internalization and delivery to lysosomes, and it
mediates the uptake of the serine protease granzyme B involved in apoptosis. MPRs reach
the cell surface via recycling endosomes from where they are rapidly internalized in CCVs in
an AP2-dependent manner.
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FIG. 2.  Overview of the subcellular trafficking itinerary of the MPRs.
MPRs bind acid hydrolases in the TGN, are packaged into AP-1-dependent CCVs and delivered to
early endosomes (EE). Hydrolases are delivered to lysosomes while MPRs are recycled back to the
TGN from EE by PACS-1-assisted packaging into AP-1-dependent CCVs or from late endosomes (LE)
mediated by TIP47 and Rab9 (Ghosh et al., 2003).
2.1.4 Other Transport Vesicles
Secretory granules are involved in regulated secretion of hormones and neuropeptides.
However, their formation does not dependent on any of the classical coatomers, and it is not
clear if any other coat protein is involved at all. Secretory granule cargo and membrane
constituents functionally substitute for classical coat proteins. The machinery underlying the
formation of secretory granules is largely unknown. The sorting signals for secretory
granules are rather heterogeneous and no classical sorting receptor has been identified.
Interestingly, secretory granules differ in size from coated vesicles and have diameter of
100-400 nm while CCVs are typically 100 nm or COP-coated vesicles 60-65 nm thick (Barlowe
et al., 1994).
MPR enters immature secretory granules from where it is removed in an AP-1-dependent
manner (Klumperman et al., 1998). In a similar way, the TGN/endosomal membrane
endoprotease furin (chapter 3.4.3) is excluded from mature secretory granules by CCVs
during secretory granule maturation (Fig. 3) (Dittie et al., 1997). This retrieval step requires
phosphorylation of the furin acidic cluster by casein kinase II (CK2) for AP-1 binding. The
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cycling of furin between the TGN, early endosomes and the plasma membrane is also
regulated via phosphorylation by CK2. Interaction with the sorting connector PACS-1 (Wan
et al., 1998) and/or AP-1 (Teuchert et al., 1999) or AP-2 clathrin adaptors (Stroh et al., 1999)
were shown to be involved in the budding reactions from endosomes, TGN or plasma
membrane, respectively. The presence of an acidic cluster within the cytosolic tail of MPR
makes it plausible that the mechanism for retrieval is similar to furin removal. AP-4 mediates
basolateral sorting of furin in polarized epithelial cells (Simmen et al., 2002), however, AP-4
was not associated with clathrin in electron microscopic studies (Hirst et al., 1999).
FIG. 3.  Scheme depicting the trafficking steps of furin.
In the TGN furin is packaged into AP-1-dependent CCVs for delivery to endosomes. Recycling to the
TGN in CCVs is assisted by PACS-1 and AP-1. Basolateral surface targeting is mediated by AP-4, and
internalization of cell-surface furin to early endosomes is dependent on AP-2. (Thomas, 2002).
2.2 Vesicle Fusion
The final step in the life of a membrane vesicle is its fusion with an acceptor membrane. The
targeting and fusion reactions depend on a class of proteins referred to as SNARES (soluble
N-ethylmaleimide-sensitive factor attachment protein receptor). v-SNAREs are found on
vesicles and bind to t-SNARES on a target membrane. Most SNAREs are transmembrane
proteins with their functional N-terminal domain facing the cytosol. The main tasks of
SNAREs are to promote vesicle fusion and to provide specificity for membrane fusion. The
assembly of a four-helix bundle trans-SNARE complex is needed to bring two membranes
close enough to each other for spontaneous fusion (Weber et al., 1998). Additional specificity
is provided by tethering factors that link opposing membranes prior to SNARE complex
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formation. EEA-1 is an example of such a tether and promotes the homotypic fusion of early
endosomes (Christoforidis et al., 1999). Tethering factors cooperate with Rab GTPases to
promote the initial association of two membranes. Furthermore, vesicle fusion is regulated
by a large array of accessory proteins such as synaptotagmin that promotes vesicle fusion in
response to Ca2+ influx (Jahn et al., 2003). N-ethylmaleimide-sensitive fusion (NSF) protein
and soluble NSF attachment protein (SNAP) (Weidman et al., 1989) are required for dissocia-
tion of the complex and SNARE recycling (Rice and Brunger, 1999).
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3. Secretory Granules and Regulated Secretion
Organisms must be able to respond quickly to changes in the environment. Hormones and
the regulated secretory pathway serve to meet this purpose (Fig. 4). All cells have a constitu-
tive secretory pathway which is considered the default pathway for protein secretion. Some
cells are specialized to synthesize and store large amounts of hormones or neuropeptides in
order to rapidly discharge them in response to a physiological stimulation. The regulated
secretory pathway exists exclusively in endocrine, neuroendocrine and exocrine cells and
involves the formation of cytoplasmic storage compartments referred to as secretory
granules (SGs) (Fig. 5). Secretory proteins are sorted into SGs where they are concentrated
and stored for regulated secretion. The release of regulated secretory proteins requires an
extracellular stimulus which triggers the fusion of SGs with the plasma membranes and
results in exocytosis of the protein content.
FIG. 4.  Regulated versus constitutive secretion.
Regulated secretory proteins are segregated in the TGN and sorted into the regulated secretory
pathway (RSP) while other proteins destined for the cell exterior follow per default the constitutive
secretory pathway (CSP).
3.1 Secretory Granule Formation
Secretory granules are morphologically characterized by their electron-dense core containing
hormones or neuropeptides, the main cargo proteins. Other proteins found in the lumen of
secretory granules are considered accessory proteins. They include granins that play a role in
packaging of the main cargo protein and proprotein convertases which are important for
proteolytic processing during granule maturation. These two important classes of proteins
are described in chapters 3.4.2 and 3.4.3, respectively.
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FIG. 5.  Electron microscopic image of the pars nervosa of endocrine glands.
Secretory granules (red arrowheads) are transported along microtubules (black arrows) to their site of
release (28'700x) (Cross and Mercer, 1993).
3.1.1 Two Models
There exist two main models to explain sorting of secretory proteins into the regulated
secretory pathway. The sorting-for-entry model suggests a receptor-mediated sorting
process (Kelly, 1987) analogous to the M6P-dependent transport of lysosomal enzymes. In a
similar way, regulated secretory proteins are specifically bound to a receptor in the nascent
secretory granule membrane or to other regulated secretory proteins that are already bound.
The aggregated complex is then packaged into a secretory granule by an unknown mecha-
nism independent of classical coatomers. Proteins that fail to interact with a receptor or a
membrane bound aggregate will follow the default pathway for constitutive secretion.
However, a specific sorting receptor awaits to be identified.
The alternative model, sorting-by-retention, proposes that sorting occurs after formation of
an initial immature secretory granule (Arvan and Castle, 1987) and as part of granule
maturation. The process is initiated by selective aggregation of regulated cargo proteins in
the TGN where low pH conditions and high Ca2+ concentrations are favorable for aggrega-
tion. An immature secretory granule containing contaminating proteins is formed by an
unknown mechanism. Captured non-granule molecules are then removed by vesicles that
bud from maturing secretory granules via constitutive-like secretion in AP-1-containing
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CCVs (Klumperman et al., 1998). The aggregated specific secretory proteins are retained in
the maturing secretory granule and become even more condensed during this process.
3.1.2 Sorting Signals
For sorting into the regulated secretory pathway no general consensus motif has been
identified. Amino acid sequence and secondary structure analysis of 15 prohormones and
propeptides revealed a degenerate Ser-Leu-Leu motif on one side of an amphipathic helix
which was suggested to serve as a targeting sequence (Kizer and Tropsha, 1991). However,
the available data on identified sorting signals are very heterogeneous and suggest that the
sorting information does not lie in a conserved primary sequence.
For instance, a C-terminally truncated and constitutively secreted form of furin was redi-
rected to the regulated secretory pathway of AtT-20 cells when fused to the 48 amino acid
C-terminal end of the prohormone convertase PC2 (Creemers et al., 1996). Fusion of the
C-terminal 51 amino acids of the processing enzyme carboxypeptidase E (CPE) to albumin
resulted in membrane association and sorting of this chimeric protein to the regulated
secretory pathway of AtT-20 cells (Mitra et al., 1994). The C-terminal segments of CPE and
PC2 form amphipathic helices which are thought to be responsible for membrane interaction
and thereby direct sorting into the regulated secretory pathway (Fricker et al., 1990). The
presence of a sorting signal in the C-terminal 38 amino acids of the prohormone convertase
PC6A was shown by inefficient entry into the regulated secretory pathway of a deletion
mutant. The isoform PC6B does not contain this C-terminal segment and does not enter the
regulated secretory pathway (De Bie et al., 1996) further underlining the presence of a sorting
signal in the C-terminus of PC6A. Disruption of a disulfide bond at the N-terminus of POMC
resulted in its constitutive secretion in Neuro2a cells suggesting that an amphipathic loop
structure stabilized by a disulfide bridge contains the sorting information for targeting
POMC to the regulated secretory pathway (Cool et al., 1995). Similarly, the reduction of the
single disulfide loop at the N-terminus of CgB with dithiothreitol resulted in its constitutive
secretion in PC12 cells (Chanat et al., 1993). The regulated secretory proteins POMC, CgA,
CgB, prosomatostatin, and proenkephalin contain a hydrophobic peak within their
N-terminal 40 amino acids that overlaps with a predicted α-helix (Gorr and Darling, 1995).
It was suggested that many regulated secretory proteins exist in a soluble and in a mem-
brane-bound form. The tight association with the granule membranes may be achieved via
these amphipathic protein segments in a pH-dependent manner. Soluble proteins cluster
around the membrane associated populations and form multimers that eventually lead to the
creation of a specialized sub-domain in the TGN membrane from which immature secretory
granules can form. It has been suggested that lipid rafts contribute to the budding of
immature secretory granules. Lipid rafts are membrane subdomains enriched in cholesterol
and sphingolipids forming a dynamic assembly of liquid-ordered phases in the lipid bilayer
(Simons and Toomre, 2000). An important property of lipid rafts is their preferential
interaction with selected proteins allowing to include or exclude proteins to variable extents.
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3.2 Granule Maturation
During maturation of immature secretory granules, homotypic fusion occurs and the
assembly of a dense core is promoted by mild acidification of the intraluminal environment
and the presence of calcium ions. In this process, regulated secretory proteins are greatly
condensed to as much as 200-fold the concentration in the Golgi. At the same time, cargo
proteins undergo proteolytic processing by proprotein convertases for precursor activation.
Processing also has an influence on cargo retention since unprocessed prohormones are
removed together with contaminating non-granule proteins (Kuliawat et al., 2000). Protein
contaminants that do not belong into the regulated secretory pathway are removed via CCVs
in so-called constitutive-like secretion (Klumperman et al., 1998). It has been proposed that
regulated secretory proteins are retained in secretory granules through association with
phospholipids of the granule membrane in particular with phosphatitylcholines, lysophos-
phatitylcholines and sphingomyelins (Laine and Lebel, 1999). Outward transport along
microtubules occurs concomitantly with all these maturation processes including condensa-
tion, processing reactions, removal of contaminants and remodeling of the granule mem-
brane. Mature secretory granules are stored in the cell periphery, near the plasma mem-
brane, for regulated exocytosis.
3.3 Exocytosis of Secretory Granules
The release of secretory granules requires several sequential stages such as tethering and
docking at the release sites, priming (conversion to a fully releasable state), triggered
membrane fusion, release of vesicle contents and retrieval of membranes. Mature secretory
granules stay either in the proximity of the plasma membrane or at some distance from it. In
PC12 cells, mature secretory granules are frequently adjacent or directly docked to the
plasma membrane even before stimulation. However, in other neuroendocrine cells, as well
as in neurons, they remain at some distance and move to the plasma membrane only when
the cell is stimulated. Rab27A and MyRIP (Myosin VIIA and Rab interacting protein) were
proposed to bridge SGs to F-actin and to control short-range movements near the plasma
membrane and towards release sites (Desnos et al., 2003). Overexpression of Rab27A or
MyRIP inhibited secretion and restricted the movement of secretory granules within the
actin cortex. The actin network forms a mesh smaller than a granule diameter, and therefore
the motion of secretory granules within the actin cortex depends on remodeling of the actin
network to promote or restrict the mobility of secretory granules and their access to the
plasma membrane. Granuphilin (a member of the synaptotagmin-like protein family) was
proposed as the principal docking factor for insulin granules and to molecularly link insulin
granules to the fusion machinery (Gomi et al., 2005). Granuphilin is a Rab27A effector and
directly binds to the plasma membrane anchored SNARE syntaxin 1 (Torii et al., 2002) and to
Munc18-1 (Coppola et al., 2002) in the closed, inactive conformation using syntaxin 1 or the
syntaxin 1-Munc18-1 complex as a recognition platform at the plasma membrane.
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FIG. 6.  SNARE complex assembly in synaptic exocytosis.
Syntaxin exists in a closed conformation (A) which needs to open for nucleation of the fusion complex
(B). Syntaxin, SNAP25 and VAMP form a four-helix bundle which brings the vesicle close to the
membrane (C). Elevated intracellular Ca2+ levels in response to an extracellular stimulus cause
opening of the fusion pore (D) (adapted from Rizo and Sudhof, 2002).
Molecularly docked granules are fusion-incompetent and need to be primed for fusion
analogous to secretory vesicles. In the priming reaction, the docking complex is resolved and
syntaxin 1 changes to an open conformation which allows to form a four-helix bundle
complex with the SNARE proteins SNAP25 and synaptobrevin/VAMP, bringing secretory
vesicle and plasma membrane toward each other (Rizo and Sudhof, 2002) (Fig. 6). Interest-
ingly, newer secretory granules are preferentially exocytosed (Solimena and Gerdes, 2003).
The youngest granules are localized in close proximity to the plasma membrane while the
older ones are to the interior of the cell. The fusion pore opens in response to an extracellular
stimulus which is often a hormone that binds to a receptor at the cell surface resulting in a
transient increase in free Ca2+ concentration. After fusion, protein complexes are disassem-
bled and recycled together with excessive membranes.
3.4 Granule Constituents
The lumen of secretory granules contains hormones or neuropeptides, proteinases, matrix
proteins, calcium ions and protons (Apps, 1997). Many luminal constituents are membrane-
associated. Integral membrane proteins include proton pumps, channels, transporters,
cytochrome b561 and proteins functioning in trafficking. The granule membrane lipids mainly
include cholesterol, phosphatidylethanolamine, (lyso)phosphatidylcholine, and sphingo-
myelin (LeBel and Beattie, 1984; Dhanvantari and Loh, 2000).
3.4.1 Hormones and Neuropeptides
Hormones and neuropeptides are the main cargo proteins of secretory granules. They are
synthesized and stored in large amounts in neuroendocrine cells to be available for instant
release. Many peptide hormones and neuropeptides are synthesized as large inactive
precursors which are cleaved into their final active form only after sequestration in secretory
granules. The precursors or parts of them assist folding or assembly of hormone subunits
and serve for efficient transport through the secretory pathway. In addition, some precursors
can give rise to different hormones depending on the available processing enzymes.
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Insulin
Insulin is the prototype of polypeptide hormones (Steiner et al., 1969). Proinsulin is synthe-
sized in pancreatic β-islet cells and plays an important role in regulating blood glucose
levels. Preproinsulin consists of an N-terminal signal peptide followed by the B-chain, a
connecting peptide, and the A-chain. Proteolytic processing and disulfide bridge formation
between A- and B-peptides leads to the generation of active insulin which is stored in
secretory granules of β-cells. In response to high glucose levels insulin is exocytosed and
released into the blood stream to induce glucose uptake in target cells.
Vasopressin and Oxytocin
The physiological role of vasopressin lies in adjusting the water balance in the kidney.
Vasopressin is synthesized in vasopressinergic neurons of the hypothalamus and reaches
kidney cells via the endocrine secretion system. The inactive prepro-vasopressin consists of
an N-terminal signal peptide, followed by the vasopressin nonapeptide, the carrier protein
neurophysin II and a glycopeptide of unknown function. The signal peptide is cleaved after
translocation into the ER; neurophysin II and the glycopeptide are cleaved by specific
convertases in secretory granules to render the biologically active vasopressin nonapeptide.
Oxytocin differs only by two amino acids from the vasopressin nonapeptide. Its precursor
contains the carrier protein neurophysin I but no glycopeptide. Oxytocin causes uterus
contraction and functions in stimulating milk production in the mammary gland.
Pro-opiomelanocortin (POMC)
POMC is a precursor for various peptides which are involved in diverse biological functions
(Raffin-Sanson et al., 2003). In a tissue-specific manner it undergoes extensive post-
translational processing mainly by PC2 and PC3. In corticotroph cells of the anterior
pituitary POMC is processed to NT (N-terminal peptide), JP (joining peptide), ACTH
(adrenocorticotrophin), β- and γ-LPH (lipotrophin), and β-endorphin. α -, β - and γ-MSH
(melanocyte-stimulating hormone), CLIP (corticotrophin-like intermediate lobe peptide), and
β-endorphin1-27 are produced in the intermediate lobe and the hypothalamus. Production of
ACTH and α- MSH has been observed in skin cells where it influences skin pigmentation.
Chemical modifications further contribute to biological activity and diversity of POMC-
derived peptides.
3.4.2 Granins
Granins are a unique group of acidic, soluble secretory proteins isolated from secretory
granules of distinct endocrine cells (Huttner et al., 1991; Taupenot et al., 2003). They have
been proposed to act as helper proteins for sorting and packaging of peptide hormones and
neuropeptides into secretory granules (Rosa et al., 1985). They are thought to act as assembly
factors which coaggregate with other secretory proteins and enable their condensation.
Chromogranin A (CgA) was the first to be discovered and has been studied extensively. It
has been considered as the index member of this family. The other six members are chromo-
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granin B (CgB), secretogranin II (SgII or CgC), secretogranin III (SgIII or 1B1075), secre-
togranin IV (SgIV or HISL-19), secretogranin V (SgV or 7B2), and secretogranin VI (SgVI or
NESP55). The granins generally have little sequence homology, apart from the N-termini and
the disulfide-bonded C-termini of CgA and CgB. They are ubiquitously distributed through-
out endocrine and neuronal tissues, and they are cosecreted with tissue-specific hormones
and neuropeptides. They are very hydrophilic with a high number of charged amino acids
and acidic isoelectric points (Table I). Granins bind calcium and aggregate in vitro at low pH
in the presence of calcium ions. These properties have been implicated in the mechanism
responsible for sorting to secretory granules. It has been reported that CgA and CgB have
granulogenic effects and are able to induce de novo secretory granule biogenesis in non-
endocrine cells (Huh et al., 2003). It has even been suggested that CgA acts as a main on/off
switch that triggers or blocks secretory granule biogenesis (Kim et al., 2001).
Property CgA CgB SgII SgIII SgIV SgV SgVI
Chromosome localization 14 (human),
21 (bovine),
6 (rat),
12 (mouse)
20 (human),
3 (rat)
2 (mouse)
2 (human),
9 (rat),
1 (mouse)
2 (mouse) ND 15 (human),
2 (mouse)
20 (human)
Amino acids
(without signal peptide)
431-445 626-657 559-586 449-507 ND 185 241
Molecular mass (kDa),
Calculated
Apparent
49-52
74-80
48-52
100-120
67.5
86
51-57
57
ND
35
21
23
27.5
55
Acidic residues (%) 25 24 20 19 ND 16 21
Isoelectric point (pI) 4.5-5.0 5.1-5.2 5.0 5.1 5.6 5.2 4.4-5.2
Multibasic sites 8-10 15-18 9 6-10 ND 3 5
Disulfide-bonded loop Yes Yes No No ND No No
Calcium binding Yes Yes Yes ND ND Yes ND
Thermostability Yes Yes Yes ND ND Yes Yes
Phosphorylation Yes Yes Yes ND ND Yes Yes
Sulfation Yes Yes Yes Yes ND Yes ND
O-glycosylation Yes Yes Yes ND ND ND Yes
N-glycosylation No Yes No No No No No
Phosphorylation Yes Yes Yes ND ND Yes Yes
TABLE 1.  Properties of granins (Taupenot et al., 2003). ND = not determined.
Interestingly, granins not only serve as granule matrix. Indeed various biological activities
have been attributed to peptides derived from granins. With the exception of SgIV (not
determined), the granins have several dibasic sites that are potential cleavage sites for
proteolytic processing. Full-length granins undergo partial proteolytic processing during
their storage in secretory granules to yield a large array of biologically active peptides. Many
of these have antifungal or antibacterial activity while some inhibit vasoconstriction or
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hormone release (Taupenot et al., 2003). Defined proteolytic products include chromofungin,
vasostatin I+II, chromacin I+II, pancreastatin, and catestatin derived from CgA or chromba-
cin and secretolytin derived from CgB. SgII is processed to secretoneurin which stimulates
the release of dopamine and has chemoattractant effects on neighboring cells.
3.4.3 Processing Enzymes
Processing enzymes are considered as accessory proteins of secretory granules. Proprotein
convertases (PCs) are required for the activation of a large array of precursor proteins. The
substrates include precursors for neuropeptides, peptide hormones, growth and differentia-
tion factors, adhesion proteins, membrane receptors, blood coagulation factors, plasma
proteins, transcription factors, viral coat proteins, and bacterial toxins (Seidah and Chretien,
1999). Their discovery was based on findings in yeast genetics. The Kex2 peptidase, a serine-
protease, was shown to be responsible for proteolytic processing of the alpha-mating factor
precursor with specificity for cleaving on the carboxyl side of paired basic residues (Julius et
al., 1984). Sequence homology analysis revealed a mammalian homolog encoded by the fur
gene which led to the identification of seven kexin-related mammalian enzymes, the family
of proprotein convertases (Fig. 7). The members include furin (SPC1), PC2 (SPC2), PC3 (PC1
or SPC3), PACE4 (SPC4), PC4 (SPC5), PC6 (PC5 or SPC6), and PC7 (LPC, PC8 or SPC7)
(Bergeron et al., 2000).
PCs are highly selective endoproteases which cleave their substrates at specific dibasic sites.
The consensus motif for processing is Arg-X-Lys/Arg-Arg↓ . The first residue on the
N-terminal side of the cleaved polypeptide is named P1, the second residue is P2, and so on.
The amino acids on the C-terminal side are named P1', P2', P3', etc. The P4 Arg is not
mandatory for cleavage, however, the presence of an Arg residue at position P6, P4 or P2
generally enhances cleavage (Hosaka et al., 1991).
Introduction 29
FIG. 7.  Structural comparison of the proprotein convertase family and their related yeast kexin and
bacterial subtilisin proteases (Thomas, 2002).
After endoproteolytic cleavage the free C-terminal basic residues are removed by members
of the metallocarboxypeptidase family such as carboxypeptidase E (CPE) (Kemmler et al.,
1973) which is targeted to the regulated secretory pathway and acts in an endocrine-specific
manner. Other members of the family are CPD (Song and Fricker, 1995) which plays a role in
processing of proteins in the constitutive secretory pathway, CPZ (Song and Fricker, 1997)
and CPM (McGwire and Skidgel, 1995).
Domain organization
All members of the PC family have a similar domain structure. An N-terminal signal peptide
is followed by the pro-segment, the catalytic domain, the P domain and a more variable
C-terminal domain which can include sorting signals, transmembrane and cytosolic do-
mains, cystein-rich regions, or amphipathic helices. PCs are initially synthesized as inactive
pre-pro-proteins targeted to the ER by the signal peptide which is cleaved by a signal
peptidase after the translocation across the ER membrane. In the next processing step the
pro-segment is autocatalytically cleaved at a dibasic site in the ER. This cleavage is important
for exiting the ER. PC2 is an exception in that it requires acidic conditions of the TGN and
secretory granules for autoactivation (Lamango  et al., 1999). PC2 is also unique for its
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interaction with the neuroendocrine protein 7B2 (SgV) in the ER which is important for
transport and activity (Muller et al., 1997). The pro-segments are suggested to act as in-
tramolecular chaperones and are essential for proper folding of convertases. After cleavage
the pro-segment stays attached to the convertase and inhibits PC activity via an interaction
with the catalytic domain. In a later compartment of the secretory pathway proteolytic
cleavage at another dibasic site of the pro-segment mediates its dissociation which results in
PC activation. This second cleavage ensures that convertases are activated only after
reaching their target compartment where the pH and Ca2+ concentrations are optimal for
activity.
The catalytic domain contains the conserved catalytic triad residues Asp, His and Ser. The
conformation of the catalytic domain is primarily responsible for substrate selectivity. The
crystal structure of mouse furin and yeast kexin revealed the exact domain fold and the
detailed architecture of the substrate binding cleft explaining the stringent requirement for
basic residues by charge-complementary pockets. The active site cleft resembles a canyon-
like crevice with a peptide loop on each side and the active site triad arranged in its center
(Henrich et al., 2003). Modeling of the structure of the other PCs revealed similar domain
folds. Differences in substrate recognition can be explained by slight charge variations in the
vicinity of the active site cleft (Henrich et al., 2005). Mutational analysis of PCs confirmed that
negatively charged residues of the catalytic pocket interact with positively charged residues
of the substrate (Creemers et al., 1993).
The P domain (or Homo B domain) is required for correct folding and stability of the
convertase. The barrel-like P domain is folded separately and is covalently linked to the
C-terminus of the spherical catalytic domain by an inter-domain linker. The two domains
interact via hydrophobic interactions and a conserved salt bridge which is thought to be
essential for the structural cohesion of PCs. All PCs, except PC7, contain a RGD motif which
is usually involved in extracellular adhesion via integrins. The structural data, however,
revealed that the Arg and Asp side-chains are exposed to different surfaces which makes
integrin binding unlikely. Mutations on the RGD motif in PC3 had effects on substrate
processing, precursor processing, enzyme stability and intracellular routing which could be
explained by a structural destabilization due to modifications in the P-domain (Lusson et al.,
1997).
The C-terminal domain is quite variable among the family members. PC2, PC3 and PC4
contain a Ser/Thr-rich region and an amphipathic helix thought to be important for hydro-
phobic interactions with TGN and secretory granule membranes. Furin, PACE4, and PC6
have a Cys-rich domain which in PACE4 and PC6A was shown to be necessary for binding
to the extracellular matrix and for substrate accessibility (Nour et al., 2005). Furin, PC6B and
PC7 have a transmembrane segment followed by a cytoplasmic tail. This domain affects
cellular sorting and has been well studied for furin (Molloy et al., 1999).
Tissue distribution and subcellular expression
Most cells do not express a single PC but rather a distinct mix thereof. Temporal and spatial
specificity of expression patterns allows for availability in various proportions and combina-
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tions at different locations. Overlapping cellular expression patterns raise the possibility of
functional redundancy. Compensation of processing events has indeed been observed in
PC2-null mice, where cleavage of proinsulin was partially compensated by other convertases
(Furuta et al., 1998). Similarly, the precursor of ß-secretase (pro-BACE) is mainly processed
by furin, but in vivo experiments showed that other PCs like PACE4, PC6A, PC6B and PC7
also process pro-BACE, although to a lesser extent (Creemers et al., 2001). Despite functional
redundancy overlapping functions of PCs seem to be minimized in vivo by the fact that they
are either not coexpressed or that they are sorted to distinct cellular compartments. Based on
their tissue distribution and intracellular localization PCs can be divided into four classes:
Class I: Furin and PC7 are ubiquitously expressed in mammalian cells. They both have a
cytoplasmic tail containing sorting signals for routing between TGN, endosomes and the cell
surface. Their strategic localization in the TGN and widespread expression patterns allow for
cleavage of various substrates that travel to the cell surface via the constitutive secretory
pathway.
Class II: PC2, PC3 and PC6A process regulated secretory proteins. They are primarily
expressed in endocrine and neuronal cells. Since they process prohormones and proneu-
ropeptides in the TGN or immature secretory granules they are sometimes referred to as
prohormone convertases. PC2 and PC3 have a differential expression pattern with a varying
relative ratio which can result in different biologically active compounds derived from a
common proneuropeptide.
Class III: PACE4 and PC6 are ubiquitously expressed and play a role in both the regulated
and the constitutive secretory pathway. PACE4 expression was observed in the TGN and at
the cell surface. PC6 exists as two C-terminal variant isoforms, named PC6A and PC6B, as a
result of differential mRNA splicing. PC6A is a soluble luminal protein targeted to the
regulated secretory pathway, while PC6B has a transmembrane domain followed by a
cytoplasmic tail and is mainly located in a Golgi compartment communicating with en-
dosomes (Xiang et al., 2000). A processed version of PC6B can be secreted, and both PC6A
and PC6B are processed at their C-termini to produce an even shorter, secreted form lacking
the cell surface anchored cystein-rich domain (De Bie et al., 1996). PACE4 expression is very
high in some restricted areas of the central nervous system and low in other regions. PACE4
and PC6 generally have non-overlapping expression patterns and are thought to be involved
in the processing of a distinct set of proneuropeptides in the nervous system and proproteins
in peripheral tissues during development (Zheng et al., 1997). PACE4 plays an important role
in patterning the early mouse embryo via TGFß-related signaling events (Constam and
Robertson, 2000).
Class IV: PC4 has a unique expression pattern and is restricted to testicular germ cells.
Subcellular expression was observed in acrosomal granules of spermatides and on the sperm
plasma membrane (Gyamera-Acheampong et al., 2005). It is thought to play a role in the
production of fertile and developmentally competent spermatozoa.
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3.4.4 Other Granule-associated Proteins
While hormones, neuropeptides, granins and prohormone convertases are efficiently sorted
into the regulated secretory pathway other proteins may be dragged into secretory granules
only to a limited extent and fulfill additional functions in other subcellular compartments.
Various transporters are found in the membranes of secretory granules including the H+-
translocating ATPase for acidification of the matrix, the H+/chatecholamine antiporter, the
vesicular monoamine transporter (VMAT), and the IP3-Receptor (IP3-R)/Ca2+ channel (Yoo,
1994; Apps, 1997).
The function of the IP3-R is not exclusive to the regulated secretory pathway. Intracellular
Ca2+ is mobilized by the signaling molecule inositol 1,4,5-trisphosphate (IP3) which interacts
with the IP3-R to release Ca2+ from intracellular stores. IP3-R is mainly located in ER
membranes where it mediates Ca2+ mobilization from the ER lumen into the cytoplasm in
response to various external stimuli. It exists as three isoforms, derived from three distinct
genes. Type 1 IP3-R is mainly expressed in brain tissue and plays a role in motor and
learning systems (Nishiyama et al., 2000). Type 2 and 3 IP3-Rs are expressed in various
tissues and mediate exocrine secretion of digestive enzymes (Futatsugi et al., 2005). Secretory
granules contain ~40 mM Ca2+ (the ER ~3 mM) and store up to 60% of intracellular calcium.
Intragranular Ca2+ is largely bound to chromogranins which is why granins were suggested
to act as Ca2+ storage proteins. CgA and CgB were shown to directly interact with the IP3-R
at an intragranular pH of 5.5 and to activate the IP3-R/Ca2+ channel (Yoo et al., 2002). All
three subtypes of the IP3-R were shown to be targeted to newly formed secretory granules
induced by CgA and CgB in NIH3T3 (Huh et al., 2005) fibroblast cells with IP3-R levels
similar to the those found in secretory granules of neuroendocrine chromaffin cells. Secretory
granules might act as an important calcium storage organelle, besides the ER, in cells
specialized for secretion. Moreover, IP3-R has been found in the nucleoplasm where it was
proposed to act in a complex with CgB and phospholipids to regulate Ca2+ release from a
putative nucleoplasmic store (Huh et al., 2005).
Cytochrome b561 and some other enzymes isolated from secretory granules are associated
with redox functions (Apps, 1997). However, the role of several other membrane proteins of
secretory granules (synaptophysin, glycoproteins, ATPase II) has remained unclear.
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AIM OF THIS THESIS
We have observed that prohormones and granins are capable of inducing the formation of
granule-like structures in constitutively secreting cells. The characterization of these struc-
tures revealed that they represent discrete organelles. The data suggest that the formation of
secretory granules is a self-assembly process which does not rely on an endocrine-specific
machinery. Alternatively, the required machinery could be latently expressed in all cells.
The goal of this work was to define the similarities and differences between granule-like
structures – induced by prohormones, granins, and prohormone convertases (PCs) in non-
endocrine cells – and real secretory granules of endocrine cells. Our studies address the
morphology of granule-like structures and their competence for storage and regulated
release of cargo proteins. We have analyzed various regulated secretory proteins for their
potency to induce granule-like structures, and we observed considerable differences in
efficiency of induction and in morphology of the structures. The granulogenic effects vary
considerably depending on the type of protein expressed.
PCs are particular as they were shown to interact with membranes. This feature has been
postulated to mediate targeting to the regulated secretory pathway (Creemers et al., 1996; De
Bie et al., 1996; Jutras et al., 2000). PC3 has even been claimed to be a transmembrane protein
exposing its C-terminal tail to the cytosol (Arnaoutova et al., 2003b). We were intrigued by
this suggestion, considering that the proposed transmembrane region contained a high
number of charged amino acids while typical transmembrane segments consist of un-
charged, mainly hydrophobic residues. Since the mode of membrane interaction has
significant implications for the mechanism of sorting we analyzed the membrane integration
of PC3. Membrane integrity and the topology of PC3 were assessed by various biochemical
assays.
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CHAPTER I
Expression of Regulated Secretory Proteins Is Sufficient to
Generate Granule-like Structures in Constitutively Secreting Cells
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Abstract
The formation of secretory granules and regulated secretion are generally assumed to occur
only in specialized endocrine, neuronal, or exocrine cells. We discovered that regulated
secretory proteins such as the hormone precursors pro-vasopressin, pro-oxytocin, and pro-
opiomelanocortin, as well as the granins secretogranin II and chromogranin B, but not the
constitutive secretory protein a1-protease inhibitor, accumulate in granular structures at the
Golgi and in the cell periphery in transfected COS-1 fibroblast cells. The accumulations were
observed in 30–70% of the transfected cells expressing the prohormones and for virtually all
cells expressing the granins. Similar structures were also generated in other cell lines
believed to be lacking a regulated secretory pathway. The accumulations resembled secre-
tory granules morphologically in immunofluorescence and electron microscopy. They were
devoid of markers of the endoplasmic reticulum, endosomes, and lysosomes, but in part
stained positive for the trans-Golgi network marker TGN46, consistent with their formation
at the trans-Golgi network. When different regulated proteins were coexpressed, they were
frequently found in the same granules, whereas a1-protease inhibitor could not be detected in
accumulations formed by secretogranin II, demonstrating segregation of regulated from
constitutive secretory proteins. In pulse-chase experiments, significant intracellular storage
of secretogranin II and chromogranin B was observed, and secretion of retained secre-
togranin II was stimulated with the calcium ionophore A23187. The results suggest that
expression of regulated cargo proteins is sufficient to generate structures which resemble
secretory granules in the background of constitutively secreting cells, supporting earlier
proposals on the mechanism of granule formation.
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Introduction
Endocrine and neuroendocrine cells possess a regulated secretory pathway in addition to the
constitutive pathway present in all cells (Burgess and Kelly, 1987). At the trans-Golgi
network (TGN), regulated cargo protein, such as peptide hormone precursors and granins,
are sorted into secretory granules where they are stored in a densly packed form. By an
external stimulus, the granules are triggered to fuse with the plasma membrane and to
release their contents in a controlled manner. The regulated secretory pathway thus requires
mechanisms to segregate regulated cargo from constitutively secreted proteins and to
package them into specialized vesicles. These membrane-bounded organelles in addition
recruit prohormone processing enzymes as well as the components necessary for lumenal
acidification, for transport of the granules to the cell periphery or along the axon, and for the
controlled fusion with the plasma membrane.
So far, little is known about the machinery that is required to generate secretory granules.
Two non-exclusive models have been proposed on how secretory granules are formed and
how specific cargo selection is accomplished (Arvan and Castle, 1998; Tooze, 1998). The first
model, termed sorting-for-entry, is analogous to receptor-mediated endocytosis and mannose-
6-phosphate receptor-dependent lysosomal transport (Schmid, 1997) where cargo binds to
receptors which in turn recruit a cytosolic coat. Similarly, regulated secretory proteins may
be selected and other proteins excluded by interaction with receptors in the TGN membrane
prior to granule formation. Consistent with this model, the propeptide of prosomatostatin
(Stoller and Shields, 1989) and a disulfide-bonded loop segment of CgB (Kromer et al., 1998;
Glombik et al., 1999) have been shown to be necessary and sufficient to mediate granule
sorting, suggesting they constitute sorting signals. An amphipathic loop of pro-
opiomelanocortin (POMC) was also found to be necessary for sorting (Cool et al., 1995).
Carboxypeptidase E was reported to bind to this loop and to be required for granule sorting
(Cool et al., 1997). Its proposed role as a sorting receptor, however, is controversial (Irminger
et al., 1997). The apparent substoichiometric amount of putative sorting receptors in secretory
granules may be explained by the tendency of regulated secretory proteins to aggregate
under the conditions of the trans-Golgi (low pH and high calcium concentrations) (e.g. ref.
Chanat and Huttner, 1991; Colomer et al., 1996)), which would allow each receptor to sort an
entire polymer of cargo molecules.
The alternative model, sorting-by-retention, proposes that selective aggregation of regulated
cargo in the TGN results in an immature granule. Captured non-granule molecules are
subsequently removed in vesicles budding from maturing secretory granules by clathrin-
coated vesicles and by so-called constitutive-like secretion, whereas specific granule cargo is
retained (Kuliawat and Arvan, 1992). This explains the presence of the mannose 6-phosphate
receptor, clathrin and AP-1 adaptors on immature secretory granules (Dittie et al., 1996;
Klumperman et al., 1998).
Recently, it has been proposed that a single protein of endocrine and neuronal cells, chromo-
granin A (CgA), controls secretory granule biogenesis (Kim et al., 2001). Expression of CgA
was even found to induce granular structures in transfected CV-1 fibroblast cells. The
interpretation of these observations has been discussed controversially (Day and Gorr, 2003;
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Huh et al., 2003; Kim et al., 2003). In the alternative view, condensing CgA might act as an
aggregation or assembly factor similarly to the sorting-by-retention model (Day and Gorr,
2003).
In this study, we report that several other cargo proteins of the regulated secretory pathway
of endocrine cells, peptide hormone precursors as well as granins, induce the formation of
granule-like structures when expressed in cell lines normally lacking regulated secretion.
Expression of cargo is sufficient to drive segregation of regulated and constitutive secretory
proteins and the formation of dense, membrane-bounded accumulations with similar
ultrastructural appearance as secretory granules, suggesting that initial granule formation
requires no additional machinery specific to regulated secretory cells besides the regulated
cargo itself.
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Materials and Methods
cDNA constructs — cDNAs for regulated secretory proteins were gifts by G. Boileau (Univer-
sity of Montreal; porcine POMC), H. Gerdes (University of Heidelberg; human SgII and
CgB), and M. Ito (Northwestern University, Chicago; human vasopressin). The coding
sequence of human oxytocin was assembled from the exons amplified by polymerase chain
reaction from the gene (a gift by J. Amico, University of Pittsburgh). The cDNA of human a1-
protease inhibitor (A1Pi) was from J.L. Brown (University of Colorado, Denver). To
C-terminally tag proteins with a c-myc epitope, a Kpn I restriction site was introduced by
polymerase chain reaction in place of the stop codon for ligation to the myc epitope sequence
encoding EQKLISEEDLNstop. In the same way, the C1 epitope ETELDKASQEPPLLstop
corresponding to the C-terminal sequence of the human asialoglycoprotein receptor H1, for
which we have a rabbit anti-peptide antiserum (Geffen et al., 1993), was fused to CgB and
SgII. The cDNAs were subcloned into the SV40-based expression plasmids pECE or pCB6.
For expression in COS-1 cells without plasmid amplification, SgII-myc was also cloned into
pcDNA5 (Invitrogen), which lacks SV40 sequences.
Cell culture and transfection — Madin-Darby canine kidney (MDCK) strain II and HepG2
hepatoma cells were grown in minimal essential medium, COS-1, chinese hamster ovary
CHO-K1, human embryo kidney HEK293, and NIH/3T3 cells in Dulbecco's minimal
essential medium, supplemented with 2mM L-glutamine, 100 units/ml penicillin, 100µg/ml
streptomycin, and 10% fetal calf serum at 37°C with 7.5% CO2. Cells were transfected using
Lipofectin (Life Technologies) with 2 µg plasmid DNA/35-mm dish at ~40% confluency and
processed after 48 h. To reduce expression levels of SgII-myc in COS cells, the SgII-myc
expression plasmid was gradually diluted with pEGFP-N1 (Clonetech), whereby the total
amount of plasmid was kept constant at 2 µg/35-mm plate. Expression levels were assayed
by immunoblot analysis using rabbit anti-secretoneurin antiserum (Kirchmair et al., 1993), a
gift from R. Fischer-Colbrie (University of Innsbruck), at a dilution of 1:1000. To generate
stable cell lines, HEK293 cells were transfected with pCB6 containing the vasopressin
precursor cDNA und subjected to selection with 1 mg/ml G418-sulfate (Gibco). Resistant
lines were cloned and analyzed by immunoblotting and immunoflurescence microscopy.
Immunofluorescence and antibodies — We used rabbit anti-neurophysin II antibodies against
pro-vasopressin (which also recognizes neurophysin I of pro-oxytocin) from ICN, rabbit anti-
human adrenocorticotropic hormone (ACTH) to detect POMC from Sigma, sheep anti-
human TGN46 from Serotech, rabbit anti-A1Pi antiserum from Jerry L. Brown (UCHSC,
Denver), rabbit anti-human EEA1 (early endosome antigen 1) antiserum from H. Stenmark
(Norwegian Radium Hospital, Oslo), rabbit anti-protein disulfide isomerase from H.P. Hauri
(Biozentrum, Basel), monoclonal antibodies against the c-myc epitope (9E10) (Evan et al.,
1985), against giantin from H.P. Hauri, against lamp-1 from J. Rohrer (FMI, Basel), against
rab5 from R. Jahn (MPI, Göttingen), and a rabbit anti-peptide antiserum recognizing the C1-
epitope (Geffen et al., 1993). Antibodies were used at a dilution of 1:100 except for anti-ACTH
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(1:200) and anti-rab5 (1:80). As secondary antibodies, non-crossreacting cy3-labeled goat anti-
mouse, cy2-labeled goat anti-rabbit, cy3-labeled donkey anti-sheep, and cy2-labeled donkey
anti-rabbit immunoglobulin antibodies (from Jackson Immunoresearch and Amersham
Biosciences) were used as appropriate according to the manufacturers' recommendations.
Cells were grown on 14-mm glass coverslips, fixed with 3% paraformaldehyde for 15 min at
room temperature, washed in phosphate-buffered saline (PBS), quenched with 50 mM
NH4Cl in PBS, and permeabilized with 0.1% Triton X-100 for 10 min. Nonspecific antibody
binding was blocked with PBS containing 1% bovine serum albumin. The fixed cells were
incubated at room temperature with primary antibodies for 1 h, washed with PBS with
albumin, and stained with fluorescent secondary antibodies in PBS with albumin for 30 min.
After several washes with PBS with albumin, PBS, and water, the cover slips were mounted
in Mowiol 4-88 (Hoechst). Staining patterns were analyzed using a Zeiss Axioplan 2 micro-
scope with a KX Series Imaging System (Apogee Instruments) or a Zeiss Axiovert 200M
confocal LSM 510 Meta microscope.
Electron microscopy — To enrich transfected cells for ultrastructural analysis, COS-1 cells were
co-transfected with an expression plasmid encoding pro-vasopressin or SgII-myc, and a
plasmid pEGFP-N1 encoding green fluorescent protein (GFP). The cells were brought into
suspension by trypsinization and were sorted for GFP fluorescence using a MoFlo cell sorter
(Cytomation, Fort Collins, CO). They were then fixed with 3% paraformaldehyde/0.5%
glutaraldehyde in PBS, pH 7.4, for 1 h at room temperature, washed with PBS, incubated
with 1% osmium tetroxide for 1 h, washed with water, and dehydrated by successive 15-min
incubations with 50%, 70%, 90%, 100% ethanol, followed by 1 h with Epon/aceton 1:1, 1 h
with Epon/aceton 2:1, and two times 2 h with Epon, and 24–48 h at 60°C. Thin sections were
stained with 6% uranyl acetate for 1 h and with lead acetate for 2 min.
For immunogold labeling, GFP-positive cells expressing SgII-myc were fixed with 3%
paraformaldehyde/0.5% glutaraldehyde in PBS for 1 h, washed with PBS, fixed again with
0.5% osmium tetroxide for 1 h, washed with water, and incubated 15 min each with 50% and
70% ethanol, 1 h with ethanol/LR White 2:1, 1 h with LR White (from Polysciences, War-
rington, PA), and 24–48 h at 60°C. Thin sections were then blocked twice for 5 min with 2%
BSA in PBS, incubated with anti-myc antibody 9E10 in 2% BSA for 3 h, washed three times
for 10 min with PBS and again two times for 5 min with 2% BSA, incubated for 1 h with goat
anti-mouse immunoglobulin (from British Biocell) coupled to 10-nm gold, washed with PBS
and with water and contrasted with 6% uranyl acetate for 1 h and with lead acetate for 2
min.
Storage and stimulation assays — To analyze the secretion behavior, COS-1 cells transfected
with A1PiTS (Leitinger et al., 1994), CgB-C1, or SgII-C1 were labeled with [35S]sulfate (0.5
mCi/ml, from Amersham, in sulfate-free medium, from Gibco) for 90 min at 19°C, followed
by a chase at 37°C for up to 6 h in medium containing excess unlabeled sulfate. The medium
was removed and replaced by fresh chase medium at different times. The labeled protein
secreted into the medium as well as that retained in the cells at the end of the experiment
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was immunoprecipitated and analyzed by gel electrophoresis and autoradiography. Signals
were quantified by phosphorimager.
To analyze stimulated secretion, COS-1 cells expressing SgII-C1 were labeled with
[35S]sulfate for 90 min at 19°C, followed by a chase of 3 h, after which the medium was
replaced by medium with or without 1 µM A23187 (Sigma; prepared by adding a 100-fold
concentrated stock solution in DMSO or just DMSO to the medium). Labeled protein
secreted into the medium during this time was analyzed by immunoprecipitation, gel
electrophoresis, and autoradiography. The total amount of labeled SgII-C1 was determined
by immunoprecipitation from the medium and the cell lysate of parallel aliquots of trans-
fected cells after the labeling period. Cell integrity as judged by trypanblue exclusion was not
affected after 30 min with 1 µM A23187.
To estimate the effect of stimulation on the density of granule-like structures, transfected
COS-1 cells expressing SgII-myc were incubated for 30 min with fresh medium with or
without 1 µM A23187, and then fixed and processed for immunofluorescence. Fifty random
cells of each condition were photographed and the granule-like structures counted, exclud-
ing the Golgi/TGN area of the cells where structures could not be separated from each other,
by a person unaware of the sample identity. The numbers were normalized for the size of the
cells as estimated by measuring the area from tracings of the cell outlines excluding the Golgi
area using Adobe Photoshop.
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Results
Pro-vasopressin expressed in COS-1 cells accumulates in granular structures — The vasopressin
precursor protein is normally expressed in specific neurons of the hypothalamus. Upon
translocation into the endoplasmic reticulum (ER), it is transported through the secretory
pathway to the TGN where it is packaged into immature secretory granules. The precursor is
processed by prohormone convertases to the nonapeptide hormone, the carrier protein
neurophysin II, and a C-terminal glycopeptide. Granules are transported to the nerve
terminals in the neurohypophysis and its contents are released as the granule membrane is
triggered to fuse with the plasma membrane.
Upon expression in transfected COS-1 cells, which lack a regulated secretory pathway, pro-
vasopressin is not proteolytically cleaved and is in its majority constitutively secreted (~85%
in 2h) (Beuret et al., 1999). When subjected to indirect immunofluorescence analysis using an
antibody directed against neurophysin II, many transfected cells showed the expected weak
staining of the ER typical of a secretory protein whose rate-limiting step in secretion is
protein folding and ER exit. In approximately 50% of the expressing cells, however, intense
additional staining was found in punctate patterns, often near the nucleus, but frequently
also in the periphery of the cells (Fig. 8A–C). The fluorescent structures varied in apparent
size between less than 0.5 µm and up to 4 µm in diameter.
In bright-field microscopy using differential interference contrast, the larger vasopressin
accumulations were visible as prominent structures (Fig. 8C’), indicating that they are
particularly dense. Cells expressing pro-vasopressin in such accumulations can often be
identified and distinguished from nontransfected cells by bright-field microscopy alone (Fig.
8C’, compare the transfected cells with the surrounding untransfected ones). This indicates
that the dense structures are newly generated by pro-vasopressin expression and do not
constitute pre-existing compartments which receive pro-vasopressin when expressed. The
appearance and density of these elements are reminiscent of secretory granules of endocrine
cells and raise the possiblity that expression of this regulated secretory protein induces the
formation of similar, granule-like structures even in a cell line with only a constitutive
secretory pathway.
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FIG. 8.  Regulated secretory proteins expressed in transfected COS-1 cells accumulate in granular
accumulations.
Transfected COS-1 cells expressing pro-vasopressin (A–C), pro-oxytocin (D), POMC (E), CgB-myc (F),
and SgII-myc (G) were analyzed by indirect immunofluorescence using antibodies against neuro-
physin, ACTH, and the myc epitope, respectively. In panel C’, the same field as in C is shown by
differential interference contrast microscopy. The micrographs are representative of ~50%, ~30%, and
~75% of the cells expressing pro-vasopressin, pro-oxytocin, or POMC, respectively. The other cells
showed low staining of ER and Golgi, as expected for a constitutively secreted protein. Essentially all
cells expressing CgB-myc or SgII-myc showed the granular accumulations as shown in panels F and
G. Bars, 20 µm.
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Granule-like structures are formed by various regulated cargo proteins — To test whether the
ability to form granule-like structures is unique to the vasopressin precursor, the cDNAs of
other granule cargo were transiently expressed in COS-1 cells and analyzed by immunofluo-
rescence. Pro-oxytocin is closely related to pro-vasopressin with 74% identity. In approxi-
mately one third of COS-1 cells expressing pro-oxytocin, a punctate pattern of accumulated
protein was detected (Fig. 8D), very similar to the finer structures generated by pro-
vasopressin. POMC, the precursor of ACTH and other active peptides of the anterior
pituitary gland, produced small granular structures in ~75% of the transfected cells (Fig. 8E).
We further tested chromogranin B (CgB) and secretogranin II (SgII), two members of the
granin family of acidic proteins found in a variety of endocrine and neuronal cells (Huttner
et al., 1991). These proteins are believed to function as helper proteins for the packaging of
peptide hormones and neuropeptides (Rosa et al., 1985). In transfected COS-1 cells, both CgB
and SgII, tagged with a myc-epitope for detection, generated a multitude of small granular
structures in virtually all expressing cells (Fig. 8F–G).
Formation of granular structures is not specific to COS cells or to high overexpression — The
formation of these accumulations in COS-1 cells may be due to the latent expression of the
putative machinery to generate secretory granules and/or to the high expression levels
obtained by T antigen-mediated amplification of the SV40-based expression plasmid used.
To test this, SgII-myc or pro-vasopressin were transfected into HepG2, NIH/3T3, MDCK II,
HEK293, or CHO-K1 cells. In all cell lines, similar accumulations were observed as in COS-1
cells (Fig. 9).
To test the influence of the expression level, COS-1 cells were transfected with the SgII-myc
plasmid increasingly diluted with an unrelated plasmid (Fig. 10A, lanes 1–4) or using an
expression plasmid lacking SV40 origin of replication and promoter sequences (pcDSg; lane
5). As judged by immunoblot analysis, the expression level was reduced at least 20-fold
relative to standard conditions. For comparison, an aliquot of PC12 cell lysate was analyzed
in parallel (lane 6). Immunofluorescence microscopy showed that the transfection efficiency
was unchanged under these conditions (~10%) and that virtually all cells expressing SgII-
myc produced granule-like structures independently of the expression level (Fig. 10A).
Correcting the immunoblot signals for transfection efficiency and taking into account
efficient storage in PC12 cells, the result suggests that formation of granular structures in
COS-1 cells does not require massive overexpression of SgII in comparison to natural
secretory granule-producing cells.
Furthermore, we generated clonal HEK293 cell lines stably expressing different levels of
vasopressin precursor (Fig. 10B). In all lines, 40–80% of the cells showed granular accumula-
tions without correlation to expression levels. Interestingly, none of the lines showed the
massive structures of more than 2 µm often observed in transient transfections, suggesting
that they might be toxic. While the formation of vasopressin accumulations does not depend
strongly on expression level, it is unknown why it is triggered in only a fraction of the cells.
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FIG. 9.  Granular structures are formed in different cell types.
HepG2 (A), NIH/3T3 (B), MDCK(C and E), HEK293 (D), and CHO-K1 cells (F) were transfected with
a plasmid encoding SgII-myc (A–D) or the vasopressin precursor (E and F) and stained with anti-myc
or anti-neurophysin antibodies and a cy3- or cy2-labeled secondary antibody, respectively. The
confocal microscope was used for panels A–D). Bar, 20 µm.
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FIG. 10.  Granule-like structures are not the result of excessive expression levels.
 (A) COS-1 cells were transfected with pESg, the cDNA of SgII-myc in the SV40-based expression
plasmid pECE, undiluted (lane 1), or with 2-, 4-, or 16-times less pESg diluted with pEGFP-N1 (a GFP
encoding SV40-based plasmid; lanes 2–4). In addition, COS-1 cells were transfected with SgII-myc
cDNA in pcDNA5 lacking SV40 sequences (pcDSg; lane 5). 30 µg of cellular protein were analyzed by
gel electrophoresis and immunoblotting. For comparison, 10 µg of PC12 cell protein was analyzed in
parallel (lane 6). The position of full-size SgII and its processing products are pointed out by large and
small arrowheads, respectively. Molecular weight markers are indicated in kDa. In parallel, cells
transfected with pESg alone (labeled 1) or with pESg diluted 4- (1/4) or 16-fold (1/16) with pEGFP-N1
were analyzed by immunofluorescence using anti-myc and cy3-labeled secondary antibodies. All cells
expressing SgII-myc showed granule-like structures. (B) Stable HEK293 cell lines expressing vaso-
pressin precursor were analyzed by Western analysis (30 µg of cellular protein per lane; –, untrans-
fected HEK293 cells) and by immunofluorescence. For all cell lines, 40–80% of the cells showed
granular accumulations of pro-vasopressin without correlation to the expression levels. Bar, 20 µm.
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A constitutive cargo protein is segregated from granule-like structures — When pro-vasopressin
was coexpressed with SgII-myc in COS-1 cells, the two proteins colocalized to the same
structures (Fig. 11A and A'). Similarly, colocalization was observed for coexpressed CgB-myc
and SgII-C1 (SgII tagged with the 10-amino acid epitope C1; Fig. 11B and B'). In contrast,
when a constitutively secreted protein, A1Pi, was expressed in COS-1 cells, the cells showed
reticular ER and perinuclear Golgi staining. Even when expressed in cells producing SgII-
myc, A1Pi (Fig. 11C and D) was not detectable in the SgII-myc accumulations (C' and D').
These results suggest that the formation of granule-like structures is specific for regulated
cargo and that there is segregation of constitutive and regulated secretory proteins.
FIG. 11.  Regulated proteins colocalize in granule-like structures whereas a constitutive cargo
protein, A1Pi, is segregated.
Transfected COS-1 cells expressing both pro-vasopressin and SgII-myc (A and A'), CgB-myc and SgII-
C1 (B and B'), or A1Pi and SgII-myc (C, D and C', D'), were double-stained with antibodies against the
two cargo proteins and appropriate cy2- or cy3-labeled secondary antibodies. Bar, 20 µm.
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Granule-like structures are post-Golgi organelles — In Fig. 12, the colocalization of organelle
markers with SgII accumulations was analyzed to test whether the protein might form
undegradable accumulations in the ER (e.g. due to misfolding), in lysosomes, or compart-
ments en route. Antibodies against the ER chaperone protein disulfide isomerase did not
colocalize with the punctate structures containing SgII (Fig. 12A). Outside the compact Golgi
area, SgII structures were devoid of giantin (Fig. 12B), a marker of the Golgi stacks, and no
colocalization was observed with the early endosome markers EEA1 (Fig. 12C) or rab5 (Fig.
12D), or with lamp-1 (lysosome-associated membrane protein-1; Fig. 12E), a marker for late
endosomes and lysosomes.
Immunolocalization of the TGN marker TGN46 in COS-1 cells expressing SgII-myc showed
the expected strong colocalization in the TGN and some staining of the granule-like struc-
tures near the center of the cell, but less or no TGN46 staining in peripheral SgII accumula-
tions (Fig. 12F–F''). This is consistent with the model that these structures are derived from
the TGN, but are losing TGN46 progressively by the budding of vesicles for constitutive-like
secretion. The same conclusions were obtained from double-labeling experiments for pro-
vasopressin structures and the ER marker p63, giantin, rab5, transferrin receptor, lamp-1, or
TGN46 (data not shown).
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FIG. 12.  Regulated cargo accumulates in post-Golgi structures.
Transfected COS-1 cells expressing SgII-myc (A and C) or SgII-C1 (B, D, E, and F) were processed for
double-immunofluorescence microscopy staining for the myc/C1 epitope and for the organelle
markers protein disulfide isomerase (PDI; ER), giantin (Golgi), EEA1 (early endosomes), rab5 (early
and recycling endosomes), lamp-1 (late endosomes and lysosomes), or TGN46 (TGN), as indicated.
The positions of some SgII-positive structures in panels F' and F'' which are positive or negative for
TGN46 are pointed out by filled or open arrowheads, respectively. Bar, 20 µm.
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Ultrastructural morphology of granule-like structures — To facilitate the analysis by electron
microscopy, COS-1 cells were transfected simultaneously with expression plasmids for the
vasopressin precursor or SgII-myc, and for green fluorescent protein (GFP). The cells were
then trypsinized and subjected to fluorescence-activated cell sorting to isolate the trans-
fected, GFP producing cells. Upon processing of cells expressing pro-vasopressin for electron
microscopy, structures of 0.4–1 µm diameter were observed that were quite homogeneously
filled with dense material and surrounded by a membrane (Fig. 13A–B) and were not
detectable in untransfected COS-1 cells.
Granule-like structures formed by SgII-myc had a very similar ultrastructural appearance
and an average size of 0.64 µm (± 0.16 µm; n=65). Unlike our anti-neurophysin antibodies,
the antibody against the myc epitope was suitable for immunogold electron microscopy.
Anti-myc antibody in combination with a secondary antibody coupled to 10-nm gold
particles clearly decorated the dense material of the granular structures demonstrating the
presence of SgII-myc (Fig. 13C–D). The granule-like structures produced in COS-1 cells are
similar in ultrastructural appearance to secretory granules observed in different endocrine
tissues, but larger, since the latter are typically only 100–400 nm in diameter (Cross and
Mercer, 1993).
FIG. 13.  Morphological analysis of granule-like structures by electron microscopy.
COS-1 cells were transfected with expression plasmids encoding GFP and either pro-vasopressin (A
and B) or SgII-myc (C and D). Fluorescent cells were selected by cell sorting and processed for electron
microscopy. Thin sections shown in C and D were decorated with anti-myc antibodies and secondary
antibodies coupled to 10-nm gold. Some gold particles are pointed out by arrowheads in panel C. The
gold density on granule-like structures was 13 times higher than that in the cytosol (including the ER,
which also contains SgII-myc). Bars, 0.5 µm.
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Storage and stimulated secretion in COS-1 cells — In pulse-chase experiments with transfected
COS-1 cells, we have previously observed that approximately 85% of newly synthesized pro-
vasopressin was secreted into the medium within 2 h (Beuret et al., 1999), and within 4 h less
than 10% was retained in the cells (data not shown). Sorting of pro-vasopressin into granule-
like structures thus appeared rather inefficient, although it has to be considered that only
half the cells expressing pro-vasopressin form accumulations. In Fig. 14, we determined the
retention efficiency of SgII-C1 and CgB-C1, which form granule-like structures in all
transfected cells. (C1-tagged proteins were analyzed, because they could be more efficiently
immunoprecipitated than the myc-tagged versions.) SgII and CgB are naturally sulfated in
the TGN and can be conveniently labeled with [35S]sulfate. As a constitutively secreted
control protein, we used A1PiTS, a version of A1Pi tagged at the C-terminus with the tyrosine
sulfation sequence SAEDYEYPS (Leitinger et al., 1994; Leitinger et al., 1995; Kromer et al.,
1998).
Transfected COS-1 cells were pulse labeled with [35S]sulfate for 90 min at 19°C to accumulate
sufficient amounts of labeled protein while retaining it in the TGN, and then chased at 37°C
for up to 6 h. At different time points, the medium was removed and replaced by fresh
medium. The labeled protein was immunoprecipitated from media and cells and analyzed
(Fig. 14). A1PiTS was almost completely secreted within the first hour of chase (lanes 1–7 and
circles). In contrast, only 70% of CgB-C1 (lanes 8–13 and triangles) and less than half of SgII-
C1 (lanes 14–19 and filled squares) was constitutively secreted within the first 2 h, and
further release was slow. After 6 h, ~10% of CgB-C1 and ~40% of SgII-C1 were still retained
intracellularly. The latter corresponds to a level of retention similar to that found for
regulated secretory proteins in endocrine cell lines (e.g. exogenous CgB in PC12 cells)
(Kromer et al., 1998).
When the cells were labeled at 37°C for 1 h (Fig. 14, lanes 20–25 and open squares), ~40% of
the labeled SgII-C1 was already secreted into the medium during the labeling period. After a
6-hour chase, ~25% was still stored intracellularly. Retention of SgII-C1 thus appears to be
increased when labeling was performed at 19°C. This is most likely due to the increased
concentration of the protein in the TGN when exit is blocked, and/or the extended residence
time in the compartment where granule formation takes place.
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FIG. 14.  Intracellular storage of CgB-C1 and SgII-C1 in COS-1 cells.
Kinetics of secretion of A1PiTS (circles), CgB-C1 (triangles), and SgII-C1 (squares) were determined by
[35S]sulfate labeling for 90 min at 19°C (lanes 1–19, and solid lines and filled symbols) or for 1 h at 37°C
(lanes 20–25, and broken line and open symbols), followed by a chase at 37°C for up to 6 h. The
medium was removed and replaced by chase medium at the indicated time points. Labeled protein in
these media (M) and in the cells at the end of the experiment (C) was immunoprecipitated and
analyzed by gel electrophoresis and autoradiography. The cumulative amounts of secreted protein is
plotted in the graph in percent of the total (average with standard deviation of 3 or 4 experiments).
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An obvious question is whether granule proteins stored in COS-1 cells can be stimulated to
be released. To test this, cells were transfected with SgII-C1 (the regulated cargo that was
most efficiently stored) were labeled for 90 min at 19°C with [35S]sulfate to load granules
with radioactive SgII-C1, and chased for 3 h with excess unlabeled sulfate to allow the
constitutively secreted protein to be released. The cells were then incubated with fresh
medium with or without the calcium ionophore A23187 for 15 or 30 min. As shown in Fig.
15A, more than 10% of the initially labeled SgII-C1 was stimulated to be secreted by the
ionophore after 15 min, and ~20% after 30 min. Based on the pulse-chase experiment of Fig.
14, this corresponds to ~20% and ~40%, respectively, of the retained pool after 3 h of chase.
Stimulated release of SgII was accompanied by a significant decrease of the average density
of granule-like structures by ~30% after 30 min incubation with A23187 (Fig. 15B; p < 0.0001
according to Student's t-test). Secretion of SgII stored in granule-like structures in COS-1 cells
can be induced by increased calcium concentration.
FIG. 15.  Stimulated secretion of SgII-C1 in COS-1 cells.
(A) Transfected COS-1 cells were labeled with [35S]sulfate for 90 min at 19°C and chased for 3 h at 37°C
with excess nonradioactive sulfate. The medium was then replaced by fresh medium with or without
1 µM A23187 for 15 or 30 min. Labeled SgII-C1 secreted during this time was analyzed by gel
electrophoresis and autoradiography in parallel with a sample representing total SgII-C1 immuno-
precipitated immediately after labeling (T). The amounts of protein secreted in the absence or
presence of stimulant are plotted in the graph in percent of total labeled SgII-C1. The average with
standard deviation of 5 determinations is shown. (B) Transfected COS-1 cells were incubated for 30
min with fresh medium with or without 1 µM A23187 and then fixed and processed for immunofluo-
rescence. The distribution of densities of granule-like structures of 50 cells, the average and standard
deviation are plotted for each condition. The density distribution is significantly different according to
Student's t-test (p < 0.0001).
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Discussion
Secretory granules of endocrine and neuroendocrine cells typically contain hormone
precursors and granins as their main cargo. We have made the observation that the hormone
precursors pro-vasopressin, pro-oxytocin, and POMC, as well as the granins SgII and CgB
are able to generate granule-like structures when expressed in cell lines lacking a regulated
secretory pathway. The observed structures resemble secretory granules with respect to
several criteria: They contain the protein at high concentrations as judged by immunofluo-
rescence, and in densely packed form, as is apparent in differential interference contrast
microscopy. They are membrane-bounded structures of similar appearance in electron
microscopy to that of certain endocrine granules in tissues, although larger. They represent
post-Golgi structures, devoid of markers of endosomes or lysosomes, but containing low
amounts of TGN46. These structures are not formed by a constitutively secreted protein.
When coexpressed with SgII, A1Pi is not found in the granule-like structures formed by SgII-
myc, which demonstrates sorting between constitutive and regulated cargo. The formation of
SgII accumulations is accompanied by significant intracellular storage as observed in pulse-
chase experiments. Incubation with the calcium ionophore A23187 induces secretion of
stored SgII.
However, the similarity of granule-like structures in COS-1 cells with secretory granules in
endocrine cells has its limitations. Storage efficiency, although quite high for SgII (Fig. 14),
was lower for CgB, and hardly measurable for pro-vasopressin (Beuret et al., 1999). The
structures were 2–3 times larger, for pro-vasopressin even more, than natural endocrine
secretory granules. The precursor proteins were not processed, because the appropriate
enzymes are not expressed. Continued release of SgII-C1 upon stimulation with A23187
during 30 min (Fig. 15) might suggest inefficient docking to the plasma membrane, slow
membrane fusion, or slow transport to the periphery of the cell. It is likely that endocrine
cells have specialized mechanisms to regulate these processes and to optimize their effi-
ciency. The effect of calcium ionophore on SgII secretion may also be related to calcium-
induced exocytosis of membranes previously observed in CHO and 3T3 cells in electro-
physiological studies (Coorssen et al., 1996; Ninomiya et al., 1996), a process that seems to
play a role in plasma membrane enlargement in differentiation and membrane repair
(Borgonovo et al., 2002).
CgB has previously been expressed in Vero cells as a GFP fusion protein and visualized in
punctate structures (Wacker et al., 1997; Rustom et al., 2002). They were interpreted as
constitutive secretory vesicles, because ~80% of labeled CgB-GFP was secreted within 2 h
(Wacker et al., 1997). After submission of our study, CgB was shown to generate granular
structures when expressed in COS-7 and NIH3T3 cells as visualized by electron microscopy
(Huh et al., 2003), in agreement with our own findings.
Our results indicate that expression of regulated cargo proteins is sufficient to perform the
initial stages of regulated secretion in the background of non-endocrine cells. The simplest
explanation is that granule formation is the result of self-organizing properties of regulated
cargo, mainly via their ability to selectively aggregate under TGN conditions of high calcium
and low pH (Chanat and Huttner, 1991; Colomer et al., 1996) and potentially to interact with
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the TGN membrane (as reported for CgB) (Pimplikar and Huttner, 1992). The forming
granule may spontaneously detach from the TGN as a result of the dynamics of fusion and
fission of the network membranes. Contaminating material destined for en-
dosomes/lysosomes or for the cell surface (such as mannose-6-phosphate receptors or
TGN46) is removed by clathrin-coated vesicles and constitutive-like secretory vesicles,
respectively, just as it is from the original TGN membrane. This corresponds to the sorting-
by-retention model and in the simplest case may not require any additonal machinery
specific for the regulated pathway up to this point. The situation may be similar to that of
von Willebrand factor precursor, a multimeric protein of endothelial cells and megakaryo-
cytes involved in platelet adhesion. Upon expression in monkey kidney CV-1 cells, struc-
tures were observed that were morphologically similar to the endothelial-specific Weibel-
Palade bodies (Voorberg et al., 1993).
Whatever machineries are involved in generating granules as observed in COS-1 cells, they
are either constitutively expressed also in non-endocrine cells or they are induced upon
expression of regulated cargo. The first possibility is supported by a study by Chavez et al.
(Chavez et al., 1996) which suggested that constitutive secretory cells such as CHO or L cells
have a cryptic regulated pathway. A significant fraction of [35S]sulfate-labeled free glycosa-
minoglycan chains were stored intracellularly and could be stimulated to be secreted by
phorbol ester or by increased cytoplasmic calcium.
Supporting the second possibility, CgA has been proposed to play the role of the master
control molecule of initiation and regulation of dense-core secretory granule biogenesis (Kim
et al., 2001), even in CV-1 cells. The interpretation of CgA as a on/off switch of granule
formation has raised controversy (Day and Gorr, 2003; Kim et al., 2003), and CgA has been
alternatively proposed to act as one of several assembly factors in granule biogenesis (Day
and Gorr, 2003). Our results indeed show that CgA is not unique in its ability to induce the
formation of granules. All five regulated cargo proteins tested in our study induced granule-
like structures in COS-1 cells, although with different efficiencies. Only a fraction of the cells
expressing pro-vasopressin, pro-oxytocin, or POMC generated granules, whereas virtually
all cells expressing SgII or CgB did so. This supports the proposed functions of granins as
assembly factors or helpers of granule formation and as carrier proteins. Similarly, it had
been observed that overexpression of CgB increased granule sorting and processing of
POMC in AtT-20 cells (Natori and Huttner, 1996). The peptide hormone precursors share the
ability to assemble into granule-like structures by themselves, although to a lesser extent
than the granins. Auxiliary granins are certainly not the only factors lacking in COS-1 cells
that increase efficiency of sorting or other steps in regulated secretion in professional
regulated secretory cells. The analysis of granule formation and function in nonendocrine
cells may be useful to identify such factors and their mechanisms of action.
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Abstract
Regulated secretory proteins have the ability to induce granule-like structures in non-
endocrine cells. Helper proteins, the granins, are more efficient than prohormones and
induce granule-like structures in all expressing cells. Upon coexpression with prohormones,
granins modulate morphology and frequency of induced structures. Stable expression
revealed that the number of granule-like structures positive for a hormone cargo is signifi-
cantly increased when secretogranin II is coexpressed. Pro-vasopressin and secretogranin II
sorted together into newly generated structures derived from trans-Golgi network mem-
branes. The granule-associated proprotein convertase (PC) PC3 and PC6A entered granule-
like structures induced by secretogranin II, however, PC3 and PC6A were also observed in
separate vesicles containing no secretogranin II. In contrast, PC2 was not found in SgII-
induced granules and did not induce granule-like structures. In addition, granule-like
structures induced by secretogranin II recruited the inositol-3-phosphate receptor supporting
a role for secretogranin II in calcium mobilization. Storage of secretogranin II varied de-
pending on cell type from hardly detectable to more than 70% of stored secretogranin II after
6 h of chase. Our findings suggest that non-endocrine cells can form minimal secretory
granules in the absence of an endocrine-specific machinery. However, additional mecha-
nisms are required for efficient sorting of accessory proteins and intracellular storage.
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Introduction
The regulated secretory pathway is exclusively found in exocrine, endocrine, and neuroen-
docrine cells where it serves for synthesis and storage of hormones and enzymes for
instantaneous release upon extracellular stimulation. In the trans-Golgi network (TGN),
proteins destined for regulated secretion are sorted away from constitutively secreted
proteins and enter secretory granules where they are stored in a densly aggregated form. It
remains unclear how secretory granules are formed. The sorting-for-entry model suggests a
receptor-mediated sorting process (Kelly, 1987) similar to the mannose-6-phosphate-
dependent transport of lysosomal enzymes (Ghosh et al., 2003). Regulated secretory proteins,
or an aggregate thereof, bind to a specific sorting receptor which allows entry into a secre-
tory granule. Proteins that fail to interact with a receptor follow the default pathway for
constitutive secretion. The sorting-by-retention model proposes the formation of an initial
immature secretory granule (Arvan and Castle, 1987). pH- and Ca2+-dependent selective
aggregation of regulated secretory proteins starts in the TGN where immature secretory
granules - including constitutive and regulated secretory proteins - bud by an as yet un-
known mechanism. Sorting occurs during the maturation process when captured contami-
nant proteins are removed from immature secretory granules by clathrin coated vesicles
(Dittie et al., 1997; Klumperman et al., 1998). However, there is also evidence for selective
sorting into the constitutive secretory pathway. A recent study showed that a truncated
version of the Golgi resident protein Cab45 is secreted without entering immature secretory
granules suggesting that its association with Golgi and/or post-Golgi membranes serves as a
means for selective sorting into the constitutive secretory pathway (Lara-Lemus et al., 2006).
Over the past years, it has been shown that at least the initial steps of secretory granule
formation can also be performed in non-specialized cell types. The granin family members
chromogranin A (CgA), chromogranin B (CgB), and secretogranin II (SgII) were shown to be
involved in this process. Overexpression of CgA in the non-endocrine fibroblast cell line
CV–1 led to the generation of large dense-core granules (Kim et al., 2001). CgA was even
suggested to control secretory granule formation acting as an on/off switch of a gene or
assembly program. The key regulatory role of CgA was called into question by the finding
that CgB proved to be even more effective than CgA in inducing granule-like structures in
COS-7 and NIH3T3 fibroblasts (Huh et al., 2003). In another study, we showed that the
hormone precursors pro-vasopressin, pro-oxytocin, and POMC, as well as the granins CgB
and SgII are capable to induce granule-like structures in various non-endocrine cells lines
such as HepG2, 3T3, MDCK, CHO, HEK293, and COS-1 (Beuret et al., 2004). The available
data suggest that a cryptic assembly program is launched in non-endocrine cells to package
and store regulated secretory proteins. The basic mechanism for the formation of secretory
granules can be induced in fibroblast-like and endothelial cells. However, the definition and
characterization of granule-like structures has caused controversy. The role of CgA was
reinvestigated by Malosio et al. (2004). CgA sorted to discrete organelles of CV-1 cells were
interpreted as post-TGN compartments destined for degradation in lysosomes. A large
fraction of transfected CgA colocalized with the lysosomal/late endosomal markers Lamp-1
and Lamp-3. In contrast, we found that granule-like structures induced by SgII (Beuret et al.,
Chapter II 60
2004) and pro-vasopressin (not shown) did not colocalize with the lysosomal marker Lamp-1
in COS-1 cells.
In this study, we analyzed the efficiency of different regulated cargo proteins to induce
granule-like structures of different morphologies and quantified these structures. We tested
the role of SgII as a helper for packaging the hormone precursor pro-vasopressin. Intracellu-
lar storage of SgII was assessed in different non-endocrine cell lines. Further, we studied the
sorting behavior of accessory proteins including the proprotein convertases PC2, PC3, PC6A,
and PC7 as well as the IP3-R/Ca2+ channel.
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Materials and Methods
cDNA Constructs — cDNAs for human SgII and CgB were gifts from H. Gerdes, University of
Heidelberg, for human pro-vasopressin from M. Ito, Northwestern University, Chicago, IL,
for porcine POMC from G. Boileau, University of Montreal, and for human oxytocin from J.
Amico, University of Pittsburg. The cDNAs encoding mouse PC2, human PC3, mouse PC6A,
and rat PC7 were gifts from W. van de Ven (Flanders Institute of Biotechnology, Leuven,
Belgium). To introduce a C-terminal C1-epitope (14 C-terminal codons of the asialoglyco-
protein receptor H1) (Beuret et al., 2004) a HindIII site was introduced by PCR in front of the
sequence encoding PC2 using the mutagenic primer CGCAAGCTTCTCACTATAGGGAGA-
CC (HindIII restriction site is underlined) and the stop coding was replaced with an Asp718
site using the primer GCGGGTACCGTTCTTTCTCAGGATACTTTG (Asp718 site is under-
lined) and fused in-frame to the C1-epitope. Similarly, PC6A was amplified with the primers
CGCAAGCTTCCGGACTCAGATCTCG (HindIII site is underlined) and GCGGGTACCGC-
CTTGGAATGTACATGTT (Asp718 site is underlined), and PC7 was amplified with the
primers CGCAAGCTTCCGGACTCAGATCTCG (HindIII site is underlined) and GCGGGT-
ACCGCAGATCTGTCCATCC (Asp718 site is underlined) for fusion to a C1-epitope at the
C-terminus (Beuret et al., 2004). The generation of PC3 constructs were previously described
(Stettler et al., 2005). To generate SgII-myc and SgII-C1 constructs, a myc or C1-epitope was
fused to SgII via a KpnI linker. The cDNAs were subcloned into the expression vectors
pECE, pCB6 or pCDNA5/FRT/TO (Invitrogen).
Cell Culture and Transfection — Human embryonic kidney (HEK) 293 T-REx cells (Invitrogen)
were cultured in Dulbecco's minimal essential medium (DMEM) supplemented with 2 mM
L-glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, 4 µg/ml blasticidin, 100
µg/ml zeocin, and 10% fetal calf serum at 37 °C with 5% CO2.
Cells were transfected using Lipofectin (Invitrogen) with 12 µg of pCB6 plasmid DNA/10-
cm dish at 40% confluency. After 48 h, cells were incubated with 1 µg/ml G418 for clone
selection. pCDNA5/FRT/TO plasmids were transfected using a CaPO4-precipitation
transfection protocol. For a 10-cm dish at 60% confluency 10 µg of plasmid DNA and 50 µg of
helper plasmid pOG44 (Invitrogen) in 0.5 ml 4 mM CaCl2 were vortexed with 0.5 ml 2x HBS
(280 mM NaCl, 1.5 mM Na2HPO4, 50 mM HEPES, pH 7.05) at room temperature and
immediately added to the cells in 5 ml fresh medium without serum. After 5 h, cells were
supplemented with 5 ml normal growth medium (without blasticidin and zeocin), and after
48 h incubated with 180 µg/ml hygromycin B and 4 µg/ml blasticidin in the absence of
zeocin for clone selection. Resistant cell lines were analyzed by immunoflorescence micros-
copy, Western blotting and β-galactosidase activity. For induction cells were incubated with
1 µg/ml tetracycline for 24 h unless indicated otherwise.
COS-1 and HeLa cells were cultured in DMEM supplemented with 2 mM L-glutamine, 100
units/ml penicillin, 100 µg/ml streptomycin, and 10% fetal calf serum at 37 °C with 7.5%
CO2. Cells were transfected with Lipofectin (Invitrogen) with 2 µg of plasmid DNA/35-mm
dish at 40% confluency and processed 48 h after transfection.
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Immunofluorescence and Immunoblotting Procedures — Antisera used for immunofluorscence
were rabbit anti-neurophysin II (NPII) for pro-vasopressin and oxytocin, rabbit anti-human
adrenocorticotropic hormone (ACTH) for POMC (Sigma), rabbit anti-A1Pi from Jerry L.
Brown (University of Colorado Health Sciences Center, Denver, CO), monoclonal mouse
anti-myc (9E10) (Evan et al., 1985), rabbit anti-C1 (Geffen et al., 1993). Antibodies were used
at a dilution of 1:100, except anti-ACTH (1:200). As secondary antibodies non-crossreacting
Cy2-labeled goat anti-rabbit and Cy3-labeled goat anti-mouse were used. For immunoblot-
ting a rabbit anti-secretoneurin antiserum (a gift from R. Fischer-Colbrie, University of
Innsbruck) was used at a dilution of 1:1000. Cells were fixed and stained as previously
described (Beuret et al., 2004).
Electron Microscopy — Affinity-purified polyclonal rabbit anti-IP3-R type I antibodies were a
gift from Seung Hyun Yoo (Inha University College of Medicine, Incheon, Korea). SgII was
stained with a mouse anti-myc antiserum or with rabbit anti-secretoneurin (a gift from R.
Fischer-Colbrie, University of Innsbruck). Pro-vasopressin was stained with rabbit anti-NPII.
The secondary antibodies used were anti-rabbit coupled to 5-nm gold and anti-mouse
coupled to 10-nm gold particles or anti-rabbit coupled to 10-nm gold. Control experiments
were performed to confirm that secondary antibodies did not crossreact.
Cells were fixed in 3% formaldehyde and 0.2% glutaraldehyde overnight at 4 °C, washed
three times with 0.1 M phosphate buffer, pH 7.4, and incubated with 50 mM NH4Cl for 30
min at room temperature. After washing three times with phosphate buffer, cells were
scraped, mixed with 10% gelatin and processed for ultrathin cryosectioning as described by
(Tokuyasu, 1989; Liou et al., 1996). Small pieces of gelatin were infiltrated on 1.725 M sucrose
and PVP solution overnight at 4°C, mounted on cutting pins, frozen in liquid nitrogen and
cryosectioned at -125°C using a Leica Ultracut UCT ultramicrotome. Sections were picked up
with 1:1 2% methylcellulose and 2.3 M sucrose and transferred to nickel grids.
For immunogold labeling cells were incubated with appropriate primary antibodies for 1-4 h
and colloidal gold-conjugated secondary antibodies in PBS containing 2% BSA for 1 h. Grids
were fixed in glutaraldehyde, washed in ddH2O, stained in 0.4% uranylacetate and 2%
methylcellulose for 10 min and viewed with a Philips CM100 electron microscope.
Storage Assay — To analyze the secretion behavior, COS-1 and HeLa cells transfected with
SgII-C1 or A1PiTS were starved for 30 min in sulfate-free medium, and pulse-labeled with
[35S]sulfate in starvation medium for 60 min at 37 °C followed by a chase of 2 or 6 h in normal
growth medium. Stable HEK293 cells were labeled with [35S]methionine for 30 min at 37°C
and chased for 6 h. Labeled protein secreted during that time as well as the fraction retained
in the cells were immunoprecipitated, analyzed by SDS-PAGE and autoradiography, and
quantified by PhosphorImager.
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Results
Granins are more efficient than prohormones in inducing granule-like structures — Besides hor-
mones, the main physiological content, there are additional major cargo proteins sorted into
secretory granules. Major constituents are the granins, a family of acidic, Ca2+-binding
proteins that have been suggested to function as helper proteins for the packaging of
hormones into secretory granules (Rosa et al., 1985; Huttner et al., 1991). We reported that
prohormones and granins are capable to induce granule-like structures when expressed in
non-endocrine cells (Beuret et al., 2004). We quantified the efficiency of granule-like structure
formation and found that granins are more efficient than prohormones. Virtually all COS-1
cells transfected with SgII or CgB produced granule-like structures (Fig. 16A and B). The
prohormones for vasopressin, oxytocin, and POMC induced granule-like structures in 51%,
39%, and 75% of transfected COS-1 cells, respectively, while the remaining cells showed
staining of the ER and Golgi only. A1Pi was used as control for a constitutively secreted
protein. As expected, 92% of A1Pi-transfected cells showed a weak staining of the ER and
Golgi, while only around 8% of cells showed accumulations. This value is markedly lower
than what we obtained for regulated secretory proteins and therefore considered as back-
ground level. When pro-vasopressin was coexpressed with SgII or CgB, the number of cells
positive for pro-vasopressin structures increased from 51% to 78% or 72%, respectively (Fig.
16C). This implies that granins assist in triggering the formation pro-vasopressin containing
granule-like structures.
Granule-like structures induced by pro-vasopressin were exceptional in that they had
different sizes often with diameters of up to several micrometers. We qualitatively classified
granule-like structures as small (<1 µm), medium-sized (1-3 µm), or large (3-4 µm) as shown
in Fig. 16B. The quantifications showed that 23% of pro-vasopressin expressing cells had
large structures, 70% were medium-sized while only 7% were of the small type. In contrast,
cells transfected with other prohormones or granins mainly produced structures in the fine
sub-micrometer size range. Interestingly, coexpression of pro-vasopressin with SgII or CgB
resulted in a change of morphology. All granule-like structures positive for both cargo
proteins appeared in the fine sub-micrometer size range. These observations support the
proposed role of granins as helper proteins (Rosa et al., 1985). Granins modulate the effi-
ciency of formation and have an effect on the morphology of pro-vasopressin containing
granule-like structures.
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FIG. 16.  Granins modulate frequency and size of granule-like structures upon co-expression with
other regulated cargo proteins in COS-1 cells.
A: Transfected COS-1 cells expressing pro-vasopressin (Vaso), POMC, and SgII-myc were stained with
antibodies against NPII, ACTH, and the myc-epitope, respectively. In the upper panel, cells with
granule-like structures are shown while the cells in the lower panel show reticular or Golgi staining.
B: Granule-like structures induced by pro-vasopressin, pro-oxytocin, POMC, SgII, and CgB were
quantified and classified with respect to morphological appearance. The constitutively secreted
protease inhibitor A1Pi was used as a control. C: The granins SgII-myc (or -C1) and CgB-C1 (or -myc)
were coexpressed with pro-vasopressin and assessed for efficiency of formation and morphological
appearance of granule-like structures. ">" indicates the percentage of cells in which at least a sub-
population of the granule-like structures were stained for both proteins. Bars, 20 µm for A, 5 µm for B.
Chapter II 65
Granule-like structures in an inducible cell system — The transient system reaches its limits
when two cargo proteins are expressed at a time. Since only a small fraction of cells are
cotransfected and expression levels can vary between individual cells, we decided to use a
stable expression system. Stable cell lines are more controlled since all cells derived from a
single clone are genetically identical and have similar expression levels. We established
stable cell lines expressing SgII-myc under the control of a tetracycline-inducible promoter in
HEK293 Flp-In T-REx cells. When expression was induced with tetracycline, all cells of the
stable clone S18 generated granule-like structures similar to the ones observed in transiently
transfected COS-1 cells (Beuret et al., 2004). Induction with 1 µg/ml tetracycline resulted in
the appearance of more granule-like structures than induction with a lower dose of 0.1
µg/ml tetracycline (Fig. 17A). Similarly, the signal detected by Western blot was dependent
on the tetracycline dose confirming that expression of SgII-myc can be tuned, and that this
leads to a dose-dependent increase or decrease of granule-like structure formation.
CgA stably expressed in CV-1 cells was shown to colocalize with the late endosomal/lyso-
somal markers Lamp1 and Lamp3 (Malosio et al., 2004). For this reason we tested our stable
cell lines for colocalization with the endosomal/lysosomal marker Lamp-1 (Fig. 17B).
However, SgII did not colocalize with Lamp-1 which makes it unlikely that the observed
structures represent accumulations in transit to lysosomes for degradation.
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FIG. 17.  SgII expression leads to the formation of granule-like structures devoid of the lysosomal
marker Lamp-1.
A: Stable HEK S18 cells were induced for 24 h with a final concentration of 0, 0.1 or 1 µg/ml tetracy-
cline (tet). Standardized amounts of cell extract were analyzed by Western blot using an antibody
against secretoneurin. In parallel, transiently transfected COS-1 cells were analyzed. The asterisk (*)
indicates a background band. For immunofluorescence analysis, SgII was stained with an antibody
against the myc-epitope. B: Stable HEK S18 cells were induced for 24 h with 1 µg/ml tetracycline and
costained with antibodies against the myc-epitope (green) and against endogenous Lamp-1 (red).
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Sorting of stably expressed pro-vasopressin is enhanced by SgII — To study the effect of granin
expression on the sorting behavior of hormones we established stable cell lines coexpressing
pro-vasopressin and SgII-myc. The cDNA encoding pro-vasopressin was inserted by
conventional random integration into the genome of HEK293 Flp-In T-REx cells. The cDNA
encoding SgII-myc was fused to the tetracycline-response element of pCDNA5/FRT/TO and
integrated into a pro-vasopressin-expressing clone by site-specific recombination with help
of the flip recombinase as described by the manufacturer. Stable clones were isolated with
help of antibiotic selection markers and tested for pro-vasopressin expression and regulable
SgII-myc expression.
Stable cell lines expressing pro-vasopressin (in the absence of SgII-myc) were analyzed for
formation of granule-like structures by immunofluorescence studies. Out of fifteen clones
positive for expression, six had granule-like structures in the majority of cells while five had
granule-like structures in only about 10% of cells. The remaining four clones had no periph-
eral accumulations at all but stained for ER, Golgi and TGN. Unlike in transiently transfected
cells, where granule-like structures induced by pro-vasopressin were often particularly big,
no large structures were observed in stable cell lines. The structures induced by pro-
vasopressin or SgII-myc had a similar size. A reason for this could be that big structures are
cytotoxic, and therefore cells generating big structures died during the antibiotic selection
procedure.
The stable cell clone V55S34 expressing pro-vasopressin continuously and SgII-myc induci-
bly, was incubated with tetracycline for 2-4 h (Fig. 18). The appearance of structures con-
taining SgII-myc was first observed after 2 h in the Golgi region where it colocalized with
pro-vasopressin. After 4 h, the majority of cells showed peripheral granule-like structures
that were positive for SgII-myc and pro-vasopressin. The data show that cargo proteins are
cosegregated into newly generated structures emerging from the Golgi.
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FIG. 18.  SgII and pro-vasopressin cosort into newly generated structures that first appear in the
Golgi region.
Stable HEK293 T-REx cells (clone V55S34) expressing pro-vasopressin continuously and SgII-myc
under the control of a tetracycline-responsive promoter were incubated with tetracycline for 2 or 4 h,
as indicated. Staining was performed with antibodies against NPII (green) and against the myc-
epitope (red). The arrows indicate the first appearance of SgII in the Golgi region. The arrowheads
indicate granule-like structures that are positive for both cargo proteins. Bar, 20 µm.
SgII helps to generate pro-vasopressin containing granule-like structures —  Clones V55S34 and
V55S40 (expressing continuously pro-vasopressin and inducibly SgII-myc) were further
analyzed for effects caused by the induction of SgII-myc. The number of granule-like
structures positive for pro-vasopressin was used as a measure to assess the helper effect of
granins. When expression of SgII-myc was induced for 24 h newly generated structures
stained positive for SgII-myc as well as for pro-vasopressin (Fig. 19A). The number of pro-
vasopressin-positive structures per cell significantly increased from 22 to 28 in clone V55S34
and from 17 to 31 in clone V55S40 (Fig. 19B; p < 0.001 according to Student's t-test). In
conclusion, SgII-myc induction had a significant effect on the generation of pro-vasopressin
containing structures, and these observations are in agreement with the proposed role of
granins as helper proteins for sorting hormones into secretory granules.
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FIG. 19.  The number of pro-vasopressin-positive structures is increased upon expressing SgII.
A: Stable HEK V55S34 cells expressing pro-vasopressin and SgII-myc were incubated with tetracycline
for 24 h (lower panel) and stained with antisera against NPII and the myc-epitope. Uninduced cells
were analyzed in parallel (upper panel). B: Uninduced (-) and induced (+) stable cell lines V55S34 and
V55S40 were analyzed for the formation of granule-like structures. In 50 randomly picked cells,
granule-like structures positive for pro-vasopressin were quantified. The total number of structures in
each cell, the average and standard deviation are plotted for both conditions. The numbers are
significantly different according to Student's t-test (p < 0.11 for V55S34, p < 0.001 for V55S40). Bar, 10
µm.
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Granule-like structures form at the TGN — Clone V55S34 was subjected to electron microscopic
analysis. Cells were induced for 5 h before treatment. Electron micrographs showed granule-
like structures emerging at the TGN (Fig. 20A-B). SgII and pro-vasopressin were detected in
the Golgi stacks and colocalized in single membrane-bound vesicles which had a diameter of
approximately 100-200 nm (Fig. 20C-E). The data show that SgII and pro-vasopressin are
cosorted into newly formed membrane vesicles. Electron microscopic data are in agreement
with the immunofluorescence analysis that also showed the appearance of granule-like
structures in the Golgi region (Fig. 18).
Immunogold labeled pro-vasopressin was occasionally also detected in multivesicular
bodies (Fig. 20F). Although we previously observed that high intracellular Ca2+ could
stimulate the release of some stored SgII, spontaneous fusion of granule-like structures may
not be the only mechanism of elimination. Eventual lysosomal delivery (e.g. by autophagy)
might also contribute to the removal in stable cell lines. Immunofluorescence analysis of
COS-1 cells (Beuret et al., 2004) and stable HEK S18 cells (Fig. 17B) showed that SgII did not
colocalize with the lysosomal marker Lamp-1 which argues against lysosomal delivery of
SgII. However, occasional colocalization of pro-vasopressin with Lamp-1 was observed (data
not shown).
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FIG. 20.  Secretory granule formation starts in the TGN where the cargo proteins pro-vasopressin
and SgII cosort into nascent vesicles.
The electron micrographs represent immunogold labeled cryosections of stable HEK V55S34 cells that
had been induced with tetracycline for 5 h. The arrowheads indicate pro-vasopressin (5 nm, empty
arrowheads) and SgII-myc (10 nm, filled arrowheads) colocalizing in membrane-bound dense-core
vesicles. For pictures A and B, cells were sequentially stained with rabbit anti-NPII, 5-nm gold
coupled anti-rabbit antiserum, rabbit anti-secretoneurin, and 10-nm gold coupled anti-rabbit
antiserum. For pictures C-E, cells were stained with rabbit anti-NPII and mouse anti-myc primary
antibodies before incubation with 5-nm gold coupled anti-rabbit and 10-nm gold-coupled anti-mouse
secondary antibodies. For picture F, sections were stained with anti-NPII and 10-nm gold coupled
anti-rabbit secondary antibodies. Bars, 200 nm for A and B, 100 nm for C-F.
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Different cell types have different storage efficiencies — Secretory granules serve as storage
compartments for hormones. In Fig. 21 we determined intracellular storage in different
fibroblast cell types. SgII was used as a regulated cargo protein because it is naturally
sulfated, and it produced granule-like structures in all transfected cells. A C-terminally
tagged version of A1Pi with the tyrosine sulfation sequence SAEDYEYPS (Leitinger et al.,
1994) was used as a control for a constitutively secreted protein. Transfected COS-1 and
HeLa cells were pulse-labeled with [35S]sulfate for 60 min at 37°C, followed by a chase for up
to 6 h. In parallel, we analyzed stable HEK293 T-REx cells expressing SgII. Because
[35S]sulfate labeling did not work in HEK cells, we pulse-labeled with [35S]methionine for 30
min at 37°C, followed by a 6 h chase. After the chase time, cells and media were immuno-
precipitated, separated by gel electrophoresis and analyzed.
In COS-1 cells, 41% of SgII was retained after a 6 h chase while 94% of A1Pi was already
secreted after 2 h. In HeLa cells, even 72% of SgII was retained after 6 h while ~90% of A1Pi
was secreted already after 2 h. For SgII, the signal after the chase time (C+M) was partially
lost in comparison to total (T) which is an indication for partial degradation. Curiously only
~4% of SgII was stored in stable HEK cells. We do not know for what reasons intracellular
storage varied between different cell types.
We also tested if SgII could influence intracellular storage of pro-vasopressin in a stable cell
system where SgII expression could be regulated. However, storage in HEK293 cells proved
to be generally poor, and we could not observe a cross-effect of SgII expression on intracel-
lular retention of pro-vasopressin (data not shown). The cellular fraction of pro-vasopressin
was not complex glycosylated (Endo H sensitive) and was possibly retained in the ER.
FIG. 21.  Intracellular storage of SgII varies between cell types.
A: COS-1 and HeLa cells transfected with SgII-C1 or A1PiTS were pulse-labeled with [35S]sulfate and
chased for 2 or 6 h, as indicated. Stable HEK293 cells expressing SgII-myc were pulse-labeled with
[35S]methionine and chased for 6 h. Cells (C) and media (M) were collected and analyzed by SDS-
PAGE. Pulse-labeled protein without chase (T) was analyzed in parallel. B: Representative experi-
ments were quantified and presented in a bar graph. C+M represent 100%. The asterisk (*) indicates a
background band.
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Prohormone convertases require additional machinery for efficient sorting into secretory granules —
Prohormone convertase (PCs) are endoproteases involved in processing and activation of
various precursor proteins (Seidah and Chretien, 1999). The endocrine-specific family
members PC2, PC3, and PC6A function in the TGN and in the lumen of immature secretory
granules. Do PCs have similar characteristics as prohormones and granins to coaggregate
with regulated cargo? Or can they even trigger the formation of an aggregate themselves?
This can be tested by expression in non-endocrine cells, either alone or together with a
granin for example, and analyzed for the formation of granule-like structures or cosorting
with the granin, respectively.
In transiently transfected COS-1 cells, only PC3 (Fig. 22A, a) was observed in granule-like
structures in around 43% of expressing cells, while PC2 (Fig. 23A, a), PC6A (Fig. 22B, a), and
PC7 (Fig. 23B, a) did not lead to the formation of granule-like structures. Similar observations
were made in stable cell lines. Stable HEK293 T-REx cells expressing PC3 (Fig. 22A, a)
showed strong staining of the Golgi and a small number of granule-like structures around
the Golgi region. Stable expression of PC2 (Fig. 23A, e), PC6A (Fig. 22B, e), and PC7 (Fig. 23B,
e) in HEK293 T-REx cells resulted in reticular and Golgi staining.
PC3 was able to induce granule-like structures, however, in markedly less efficient way than
granins. The other tested members of the PC family were not observed in granule-like
structures. PCs may thus require additional machinery or the help of aggregating proteins,
such as granins, for segregation into granule-like structures. To test the requirement for
granins we cotransfected COS-1 cells with SgII together with either PC2, PC3, PC6A, or PC7.
As expected, SgII was observed in the Golgi and in granule-like structures throughout all
cells. PC3 and PC6A colocalized with some SgII structures (Fig. 22A and B, b-d), however,
many SgII structures were devoid of PC3 and PC6A. Cosorting was not as efficient as when
SgII assisted sorting of pro-vasopressin which resulted in colocalization in virtually all
granule-like structures (Fig. 19). PC2 and PC7 were not detected in granule-like structures
induced by SgII (Fig. 23A and B, b-d). These data were confirmed in stable HEK293 T-REx
cells in which PC2, PC3, PC6A or PC7 was permanently expressed and SgII under the
control of a tetracycline-inducible promoter. When SgII expression was induced for 24 h, it
was detected in granule-like structures throughout the cells. PC3 and PC6A colocalized with
SgII in a fraction of the granule-like structures (Fig. 22A and B, f-h), while PC2 and PC7 did
not colocalize with SgII in granule-like structures (Fig. 23A and B, f-h).
In summary, PC3 and PC6A were inefficiently sorted into granule-like structures induced by
SgII. It is possible that both proteins have affinity to SgII and therefore coaggregate. In
contrast, PC2 and PC7 were not sorted into SgII structures at all. This suggests that efficient
sorting requires additional machinery which may be exclusive to endocrine cells.
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FIG. 22.  PC3 and PC6A colocalize with SgII in a large fraction of granule-like structures.
A: PC3-C1 was either expressed alone (a and e) or together with SgII-myc (b-d and f-h). Transiently
transfected COS-1 cells (a-d) and stable inducible HEK293 T-REx cells (e-h) were stained with
antibodies against the C1-epitope (green) and the myc-epitope (red). B: PC6A-C1 was either expressed
alone (a and e) or together with SgII-myc (b-d and f-h). Transiently transfected COS-1 cells (a-d) and
stable inducible HEK293 T-REx cells (e-h) were stained with antibodies against the C1-epitope (green)
and the myc-epitope (red).
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FIG. 23.  PC2 and PC7 do not colocalize with SgII in granule-like structures.
A: PC2-C1 was either expressed alone (a and e) or together with SgII-myc (b-d and f-h). Transiently
transfected COS-1 cells (a-d) and stable inducible HEK293 T-REx cells (e-h) were stained with
antibodies against the C1-epitope (green) and the myc-epitope (red). B: PC7-C1 was either expressed
alone (a and e) or together with SgII-myc (b-d and f-h). Transiently transfected COS-1 cells (a-d) and
stable inducible HEK293 T-REx cells (e-h) were stained with antibodies against the C1-epitope (green)
and the myc-epitope (red).
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The IP3-Receptor is recruited to the membranes of SgII granule-like structures — The IP3-R/Ca2+
channel, involved in Ca2+ mobilization from the ER, was shown to be enriched in secretory
granules of NIH3T3 cells induced by CgA and CgB to similar levels as in secretory granules
of neuroendocrine cells (Huh et al., 2005). Therefore, secretory granules were postulated to
play a role as an intracellular Ca2+ storage organelle with granins acting as calcium ion
absorbents. CgA and CgB were shown to directly interact with IP3-R and to activate the
inositol 1,4,5-trisphosphate receptor/Ca2+ channel (Yoo et al., 2002). CgA, CgB, and SgII
belong to the granin family and have a high Ca2+ binding capacity. It was therefore of interest
to see if IP3-R is recruited to the membranes of granule-like structures induced by SgII. IP3-R
could possibly be recruited by direct interaction of its luminal part with SgII, or alternatively,
it enters secretory granules by default due to its abundance in TGN membranes. Cryosec-
tions of HEK S18 expressing SgII were decorated with immunogold labeled antibodies
directed against secretoneurin and IP3-R. The electron micrographs in Fig. 24 show that SgII
was detected in the lumen of electron-dense structures (dark zones) while IP3-R was
detected on the surrounding membranes. This is consistent with the function of IP3-R as a
membrane Ca2+ channel, and the results are in agreement with the findings of Huh et al.
(2005). Besides, the IP3-R is the first example of a protein of neuroendocrine secretory
granules that was shown to be recruited to the membranes of granule-like structures.
FIG. 24.  SgII and IP3-R localize to granule-like structures.
HEK S18 cells expressing SgII-myc under the control of a tetracycline-responsive promoter were
induced for 24 h. Cells were stained with primary antibodies directed against the myc-epitope and the
IP3-R and secondary antibodies conjugated to 10-nm (SgII, filled arrowheads) and 5-nm (IP3-R, empty
arrowheads) gold particles. Bar, 100 nm.
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Discussion
Granule-like structures are induced in non-endocrine cells when a regulated secretory
protein is expressed. We observed that only a fraction of the cells expressing pro-
vasopressin, pro-oxytocin, or POMC generated granule-like structures, and in the case of
pro-vasopressin the structures were considerably bigger than for other cargo proteins. The
granins SgII and CgB induced granule-like structures in all transfected cells. In general, we
observed that granins had a stronger granulogenic effect than prohormones. Interestingly,
when SgII was coexpressed with pro-vasopressin, the number of structures containing a
prohormone was increased and their morphology changed to the small type usually
observed for cells expressing granins alone. In addition, we found that SgII expression in the
background of a stable cell line expressing pro-vasopressin leads to a higher number of
granule-like structures containing pro-vasopressin per cell. These structures were positive
for both expressed cargo proteins as shown by immunofluorescence (Fig. 19) and electron
microscopy (Fig. 20). The efficiency of granule formation was clearly increased and newly
generated structures received both cargo proteins. These observations suggest that SgII plays
a helper role in generating granule-like structures and in sorting other cargo proteins into
them.
When stable V55S34 cells expressing pro-vasopressin were induced for expression of SgII for
24 h some granule-like structures still only contained pro-vasopressin. Even after a pro-
longed incubation time of 11 days (data not shown) some structures (<1%) were devoid of
SgII. This can be explained by observations made by Solimena and Gerdes (2003) where
secretory granules were tagged with a DsRed dye that changed color over time. The authors
found that newly generated secretory granules are preferentially exocytosed while older
ones remain in the cells for prolonged times. The pro-vasopressin-positive granule-like
structures observed after more than a day of induction could therefore represent old
structures that stayed in the cell for a long time.
Electron microscopy showed that granule-like structures are formed at the TGN. Upon SgII
induction pro-vasopressin cosorted with the granin and newly generated granule-like
structures could therefore be easily distinguished from old structures. In our system,
granule-like structures are not positive for Lamp-1 arguing against granule-like structure
forming in the degradative pathway to lysosomes. However, pro-vasopressin and SgII were
occasionally detected in multivesicular bodies, suggesting that in the absence of an efficient
secretion mechanism (e.g. missing transport and plasma membrane docking mechanism, and
SNAREs) granule-like structures may also be eliminated by autophagy.
We also investigated the sorting mechanism of accessory proteins. Sorting of the proprotein
convertases PC3 and PC6A into granule-like structures was facilitated by SgII, however,
cosorting was not as efficient as observed for pro-vasopressin and SgII. Yet PC2 was not
sorted into granule-like structures at all. Its mechanism for sorting appears to require other
endocrine-specific proteins. 7B2 was shown to be required for efficient transport, folding,
and activation of PC2 (Benjannet et al., 1995; Zhu and Lindberg, 1995). 7B2 might be such a
factor which is required for efficient sorting of PC2 into SgII-containing granule-like struc-
tures. PC7 is special in that it is a transmembrane protein with a cytoplasmic domain. It is
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believed to traffic between TGN and plasma membrane, similar to furin, and it is usually not
found in mature secretory granules. However, furin is incorporated into immature secretory
granule from where it is recycled to the TGN prior to vesicle maturation via CCVs (Dittie et
al., 1997), and this may also be the case for PC7. In transiently transfected COS-1 cells, PC7
expression showed reticular staining and was also observed at the cell surface (Fig. 23B, a)
which is an indication for cell surface trafficking of PC7. PC2, PC3, and PC6A are luminal
proteins, and it has been shown that an amphipathic α-helix close to the C-terminus is
required for membrane interaction and sorting of these enzymes. However, our data suggest
that there must be other mechanisms for PC sorting than membrane interaction, aggregation
or coaggregation with secretory cargo proteins.
We observed that intracellular storage of secretory proteins varied between non-endocrine
cell types. After a 6 h chase, SgII storage was ~40% in COS-1 and even more than 70% in
HeLa cells while virtually no storage was observed in HEK293 cells. Our previous results
showed a lower storage efficiency in COS-1 cells where only 20% of pulse-labeled CgB, and
45% of SgII (25% when labeling was performed at 37°C) was retained after a chase time of
6 h (Beuret et al., 2004). When CgB was stably expressed in MDCK cells, ~20% of pulse-
labeled CgB was retained after a 2 h chase (Wacker et al., 1997). Pulse-chase experiments to
analyze the intracellular retention of CgA revealed that ~20% was stored in CV-1 cells after a
3 h chase (Malosio et al., 2004). Although in PC12 cells 99% of labeled endogenous CgA was
retained in the cells after 3 h, a significant amount of transfected CgA was stored in CV-1
cells. Interestingly, only ~70% of vaccinia-expressed CgB was sorted in PC12 secretory
granules after a 90 min chase (Kromer et al., 1998). A possible explanation for the different
storage efficiencies observed between cell types could be explained by variations in TGN
conditions. The most obvious conditions known to be important for aggregation of secretory
granule cargo are an acidic pH and high Ca2+ concentrations. The luminal pH of organelles in
the regulated secretory pathway becomes more acidic in the progress of the pathway (pHER
7.2-7.5, pHGolgi 6.2-6.6, pHSG 5.0-5.5) (Machen et al., 2003). Similarly, calcium ion concentra-
tions increase from 3 mM in the ER to 10 mM in the TGN to 20-50 mM in the lumen of
secretory granules (Chanat and Huttner, 1991). The pH in the TGN was determined to be
6.38 in HEK293 cells (Machen et al., 2003), 6.58 in HeLa cells (Llopis et al., 1998), and 6.17 in
human skin fibroblasts (Seksek et al., 1995) (Vero 6.45, CHO 6.25). In neuroendocrine cells,
however, the values are similar with a pH 6.2 in the Golgi of AtT-20 cells (Wu et al., 2001).
Considering the small variations between pHTGN values and the rather average value for
HEK293 cells, it seems unlikely that differences in TGN acidity could account for the low
storage efficiency of HEK293 cells.
Our results indicate that the initial steps of secretory granule formation are based on a self-
assembly process. However, sorting of accessory proteins, efficient storage, transport, and
fusion require mechanisms that are not present in fibroblasts.
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Abstract
Proprotein convertase PC3 (also known as PC1) is an endopeptidase involved in proteolytic
processing of peptide hormone precursors in granules of the regulated secretory pathway of
endocrine cells. Lacking any extended hydrophobic segments, PC3 was considered to be a
secretory protein only peripherally attached to the granule membrane. Recently, evidence
has been presented that PC3 is a transmembrane protein with a 115-residue cytoplasmic
domain and a membrane-spanning segment containing eight charged amino acids [Arnaou-
tova, I., et al. (2003) Biochemistry 42, 10445-10455]. Here, we analyzed the membrane topology
of PC3 and of a PC3 construct containing a conventional transmembrane segment of 19
leucines. Alkaline extraction was performed to assess membrane integration. Exposure to the
cytosol or to the ER lumen was tested by addition of C-terminal tags for phosphorylation or
glycosylation, respectively. Protease sensitivity was assayed in permeabilized cells. The
results show that the C-terminus of PC3 is translocated across the endoplasmic reticulum
membrane. Furthermore, the proposed transmembrane segment of PC3 and a similar one of
carboxypeptidase E did not stop polypeptide translocation when inserted into a stop-transfer
tester construct. PC3 is thus not a transmembrane protein. These results have implications
for the mechanism of granule sorting of PC3 as well as for the topology of PC2 and car-
boxypeptidase E, which have been reported to span the lipid membrane by homologous
charged sequences.
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Introduction
Intracellular processing and maturation of prohormones and proneuropeptides is achieved
by common proteolytic mechanisms. The processing enzymes include a family of endopep-
tidases, the proprotein convertases (PCs), that cleave hormone and neuropeptide precursors
at dibasic sites (Steiner, 1998; Zhou et al., 1999; Thomas, 2002), and a family of metallo-
carboxypeptidases that selectively remove the basic amino acids exposed at the new
C-termini (Fricker, 1988b). PCs belong to the kexin/subtilisin family of serine proteases.
Eight mammalian PCs have been identified. They share a common organization, illustrated
in Fig. 26A for PC3 (also known as PC1 or PC1/3), with an N-terminal signal peptide for
targeting to the endoplasmic reticulum (ER), a propeptide, a catalytic domain, a P-domain,
and a variable C-terminal segment. In the case of PC3, the prodomain is autocatalytically
cleaved already in the ER, converting the ~95-kDa full-length precursor to a ~85 kDa
intermediate. In secretory granules, a further autoproteolytic cleavage occurs at the
C-terminus of the P-domain, producing a ~64-kDa form with full enzymatic activity.
Some members of the PCs (furin, PC6/6B, and PC7) contain an obvious transmembrane
segment in their C-terminal domain and are thus type I membrane proteins. The other
members of the family (PC1/3, PC2, PC4, PC5/6A, and PACE4) were generally assumed to
be fully translocated into the ER lumen as soluble or peripherally membrane-associated
proteins. Indeed, in vitro-translated PC2 and PC3 were shown to associate with TGN/secre-
tory granule membranes and lipid rafts (Blazquez et al., 2000; Blazquez et al., 2001). In
addition, PC2 and PC3 contain a C-terminal sequence potentially forming an amphipathic
helix associating to membranes peripherally. However, evidence has recently been presented
based on protease protection, antibody binding, and chemical modification experiments with
purified secretory granules, suggesting that PC3 is in fact a type I transmembrane protein
with a cytoplasmic C-terminus (Arnaoutova et al., 2003b) (Fig. 25). The sequence proposed to
act as the membrane-spanning segment was identified as residues 619–638, directly adjacent
to the P-domain (QNDRRGVEKMVDPGEEQPTQENPKENTLVS).
Similarly, residues 617–634 at the very end of the 40-amino acid C-terminal domain of PC2
were proposed to function as a transmembrane anchor mainly based on membrane-
impermeant biotinylation of purified chromaffin granules (Assadi et al., 2004) (SKLAMSKK-
EELEEELDEAVERSLKSILNKN-COOH).
These sequences were initially identified by similarity to the C-terminal sequence of car-
boxypeptidase E (CPE), which on isolated secretory granules was found to be sensitive to
carboxypeptidase Y digestion and accessible to antibodies against the C-terminus
(Dhanvantari et al., 2002) (FELESFSERKEEEKEELMEWWKMMSETLNF-COOH).
The transmembrane topology of these proteins is of particular importance, because these
sequences and the potentially cytoplasmic domains are implicated in lipid raft association
and sorting into the regulated secretory pathway. CPE was even proposed to function as a
sorting receptor for regulated secretion (Cool et al., 1997), although this has remained
controversial (Irminger et al., 1997). The C-terminal portion of CPE was shown to interact
with ADP-ribosylation factor 6 (ARF6) in yeast two-hybrid assays and pull-down experi-
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ments (Arnaoutova et al., 2003a). A fusion protein of the luminal portion of the IL-2 receptor
a subunit and the 25 C-terminal residues of CPE behaved as a raft-associated protein
showing ARF6-dependent recycling from the plasma membrane to the TGN (Arnaoutova et
al., 2003a), supporting a membrane-spanning topology of the protein.
However, the three proposed transmembrane segments are highly unusual, since they are
composed of 40–60% charged residues, predominantly glutamates. Conventional transmem-
brane sequences consist of 16–25 uncharged, mainly hydrophobic residues. In single-
spanning membrane proteins, charged residues are virtually absent in the core of the lipid
bilayer (Reithmeier and Deber, 1992; Landolt-Marticorena et al., 1993). In the exceptional case
of individual intramembrane charges in transmembrane segments, they may cause ER
retention and degradation, unless neutralized by hetero-oligomerization with a comple-
mentary partner protein (Cosson et al., 1991).
FIG. 25.  Possible topologies of PC3.
In the left side of the sketch PC3 adopts a transmembrane topology as suggested by Arnaoutova et al.
(2003b). A fully luminal version of PC3 is shown on the right side. The puative transmembrane
domain is depicted in red.
Because of the physiological importance of the question whether these prohormone pro-
cessing enzymes are membrane-spanning proteins due to a novel type of transmembrane
segment, we set out to test the membrane disposition of PC3 using methods developed to
analyze membrane protein topology. We chose PC3 as the protein to be investigated, because
the proposed membrane-spanning segment is further inside the polypeptide chain. Modifi-
cations at the C-terminus of PC3 are 115 amino acids downstream of the proposed trans-
membrane domain, and it can therefore be excluded that they affect membrane insertion and
topology. We also analyzed the proposed transmembrane segments of PC3 and CPE in a
stop-transfer tester construct for their ability to stop translocation of a polypeptide across the
ER membrane. The results consistently show that these sequences, unlike a hydrophobic
Leu19 sequence, are unable to integrate into the ER membrane and that PC3 is not a trans-
membrane protein.
Chapter III 83
Materials and Methods
DNA constructs — The cDNA of human PC3 was a generous gift by Wim van de Ven
(Flanders Institute of Biotechnology, Leuven). To insert a classical transmembrane domain of
19 consecutive leucines, a Bgl II site was introduced by polymerase chain reaction (PCR) in
front of the sequence encoding the oligoleucine segment of H1∆QLeu19 (Wahlberg and
Spiess, 1997) using the mutagenic primer GCGAGATCTGTTGCTTTTGCTGCTG and fused
in-frame to the 5' portion of PC3 up to the BamH I site at codon 625. The 3' portion of PC3
was amplified with the primer CGCAGATCTGGGGAGGAGCAGCCC introducing a Bgl II
site before codon 627 and ligated in-frame into the BamH I site at the end of the oligoleucine
sequence. In the wild-type PC3 sequence and the oligoleucine insertion mutant, the stop
codon was replaced by the sequence of an Asp718 site by PCR using the antisense primer
CGCGGTACCAGAATTTTCCTCATTCAGAATGTC and fused via Asp718 to the C-terminal
14 codons of the asialoglycoprotein receptor H1, which encode the C1 epitope recognized by
a rabbit anti-peptide antiserum (Beuret et al., 2004).
To introduce a C-terminal glycosylation tag, the C-terminal 40 codons of H1∆L22[110]
(Goder and Spiess, 2003), which encode residues 141-160 of H1 with an N-glycosylation site
and the C1 epitope, were amplified with a primer introducing a 5' BrsG I site to be ligated
into the Asp718 site at the 3' end of the PC3 or PC3-L19 sequences. Similarly, the sequence of
the C1 epitope was amplified with a primer containing a BsrG I site, and the sequence
encoding the consensus heptapeptide sequence for phosphorylation by protein kinase A and
ligated to the PC3 or PC3-L19 sequences. The resulting C-terminal peptide extensions of PC3
are shown in Fig. 26C.
To generate a size marker for unprocessed PC3, the segment encoding the signal sequence
(codons 2–26) was deleted from the cDNA of C1-tagged PC3 by PCR using the primer GCG-
AAGCTTACCATGGCGAAAAGGCAATTTGTC (the Hind III site used for subcloning is
underlined). cDNA constructs encoding H1 and H1-M (lacking the transmembrane domain)
were described previously (Spiess and Lodish, 1986).
The stop transfer tester constructs STT and STT-H138–65 were derived from plasmids pSA0
and pSAA described previously (Wessels and Spiess, 1988; Spiess et al., 1989). Codons
599–657 of PC3 and codons 409–476 of CPE were amplified using primers providing a 5'
Acc I and a 3' Cla I site for ligation into the Cla I site of pSA0. All constructs were verified by
sequencing and inserted into the expression plasmid pECE (Ellis et al., 1986).
In vivo expression and labeling — COS-1 cells were grown in Dulbecco's modified Eagle's
minimal essential medium supplemented with 10% fetal calf serum, 2 mM L-glutamine,
100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C with 7.5% CO2. Transient transfec-
tion was performed with lipofectin (Life Technologies) according to the manufacturer's
protocol in 6-well clusters. The cells were processed 2 days after transfection.
Transfected cells were starved for 30 min in methionine-free medium, labeled with
100 µCi/ml [35S]methionine in starvation medium for 30 min at 37°C, and washed with cold
phosphate-buffered saline (PBS). The cells were lysed and immunoprecipitated using a
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rabbit antiserum directed against the C1 epitope. The immune complexes were isolated with
protein A-Sepharose, analyzed by SDS-polyacrylamide gel electrophoresis and phos-
phorimaging. For deglycosylation, immune complexes were incubated in 50 mM
K-phosphate, 25 mM EDTA, 2% Trition X-100, 0.2% SDS, 1% 2-mercaptoethanol, in the
presence or absence of 0.2 mU or 5 mU endoglycosidase H (for partial or complete deglyco-
sylation, resp.) for 1 h at 37°C.
For labeling with [32P]phosphate, cells were starved in phosphate-free medium and labeled
for 30 min with 100 µCi/ml g-[32P]ATP in the presence of 20 µM forskolin. Cells were lysed
in the presence of phosphatase inhibitors (500 µM nitrophenyl phosphate, 50 µM sodium
orthovanadate, 1 mM sodium fluoride, 1mM EDTA) and further processed as above.
For Western analysis, cells were boiled in SDS-sample buffer, proteins separated by gel
electrophoresis and transferred to polyvinylidene fluoride membrane that was then incu-
bated in blocking buffer (PBS with 0.1% Tween-20 and 5% nonfat dry milk) for 60 min and
with anti-C1 antibody in blocking buffer for 60 min at 4°C. Bound antibody was detected
using horseradish peroxidase-conjugated anti-rabbit immunoglobulin secondary antibody
and the ECL kit (Amersham Biosciences).
Alkaline extraction and protease protection — [35S]Methionine-labeled cells were extracted under
alkaline conditions as described previously (Wessels et al., 1991) by homogenization in
Hepes buffer, pH 11.5, for 15 min on ice. One half of each sample was centrifuged through a
sucrose cushion, and the membrane pellet, the supernatant, and the untreated sample were
immunoprecipitated separately and analyzed. For protease protection, [35S]methionine-
labeled cells were swollen in 15 mM Hepes/KOH, pH 7.2, 15 mM KCl, scraped, pelleted, and
resuspended in 1.2 ml PBS. Aliquots were incubated for 30 min on ice with or without
200 µg/ml trypsin or with trypsin and 1% Triton X-100. Reactions were stopped with
400 µg/ml soybean trypsin inhibitor before immunoprecipitation and analysis by SDS-gel
electrophoresis and autoradiography.
Chapter III 85
Results
To test membrane insertion of PC3, its sequence was extended by short carboxyterminal
diagnostic tags, as shown in Fig. 26A to reveal the disposition of the C-terminus of the
protein. PC3-g has a 22-residue extension with an efficient site for N-glycosylation to report
exposure of the C-terminus to the ER lumen. In contrast, PC3-p is tagged with a 9-amino acid
consensus sequence for phosphorylation by cAMP-dependent protein kinase in the cytosol
(Hjelmquist et al., 1974; Kemp et al., 1977; Goder et al., 2000). These two constructs and the
wild-type sequence were furthermore provided with a 16-residue C1 epitope for efficient
immunoprecipitation. As a further control, a conventional transmembrane domain com-
posed of an uninterrupted stretch of 19 leucine residues (L19) was inserted into the region of
the proposed stop-transfer sequence of PC3, generating PC3-L19, PC3-L19g, and PC3-L19p
(Fig. 26A and C).
FIG. 26.  PC3 constructs to study membrane topology.
A: The domain organization of PC3 and derived constructs are schematically shown. PC3 consists of a
signal sequence (ss), the pro-domain (pro), the catalytic portion, the P-domain, and a C-terminal
segment that is variable among the PC family members. The proposed transmembrane segment
(residues 619–638) is highlighted in red with a question mark. Potential glycosylation sites are indicated
by diamonds. Vertical arrows indicate cleavage sites (in parenthesis where cleavage is slowed down by
insertion of the L19 sequence). The leucine19 sequence inserted into the proposed transmembrane
segment, the C1-epitope tag, the glycosylation, and the phosphorylation tags are indicated by L19, C1,
g, and p, respectively. B: Schematic representations of the stop-transfer tester construct (STT) and its
derivatives containing the signal-anchor of the asialoglycoprotein receptor H1 (H138–65), segment
599–657 of PC3, or 409–476 of CPE are shown. C: The amino acid sequences of the relevant elements in
the PC3 and STT constructs shown in panels A and B are listed. A dot represents the C-terminus and
asterisks the residues modified by glycosylation or phosphorylation.
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PC3 is solubilized upon alkaline extraction — Under strongly alkaline conditions (pH >11)
biological membranes have been shown to be converted to open membrane sheets. Soluble
and peripheral membrane proteins are released, whereas integral membrane proteins
generally remain embedded in the lipid bilayer and are pelletable (Fujiki et al., 1982). This
method proved to be a useful empirical procedure to identify integral membrane proteins.
PC3 and PC3-L19 were transiently expressed in COS-1 cells in parallel with the asialoglyco-
protein receptor H1, a single-spanning type II membrane protein, and H1-M, the same
protein lacking its transmembrane segment, as controls. Cells were labeled with
[35S]methionine for 30 min and then extracted at pH 11.5. Extracted material and membranes
were separated by centrifugation through a sucrose cushion. Total material, pellet, and
supernatant were analyzed by immunoprecipitation, SDS-gel electrophoresis, and autora-
diography (Fig. 27). As expected, H1 was recovered exclusively in the membrane pellet
(lanes 7–9) and H1-M in the soluble fraction (lanes 10–12). PC3 was produced as a single
species of the expected apparent molecular weight of ~85 kDa, corresponding to the protein
lacking its N-terminal pro-domain (lane 1). It was efficiently extracted into the supernatant
(lanes 1–3). Expression of PC3-L19 generated two products differing in size by ~8 kDa (lane
4). The two species correspond to the pro-form and the N-terminally processed form. The
presence of the oligoleucine sequence appears to slow down autocatalytic cleavage of the
pro-domain. Both forms of PC3-L19 remained completely membrane associated due to the
oligoleucine sequence (lanes 4–6). The proposed transmembrane segment of PC3 thus cannot
anchor the protein in the lipid bilayer under alkaline conditions. However, while alkaline
extraction as an empirical method provides quite reliable results for conventional membrane
proteins, the proposed PC3 transmembrane segment rich in glutamate and aspartate under
harsh deprotonating conditions may follow different rules.
FIG. 27.  PC3 is released from the membrane upon alkaline extraction.
Transfected COS-1 cells expressing PC3, PC3-L19, H1, or H1-M were labeled with [35S]methionine for
30 min and subjected to alkaline extraction and centrifugation to separate soluble and membrane
integrated proteins. The total before centrifugation (T), and the supernatant (S) and membrane pellet
(P) after centrifugation were analyzed by immunoprecipitation, SDS-gel electrophoresis, and
autoradiography. The positions of marker proteins with their molecular weights in kDa are indicated.
Chapter III 87
The C-terminus of PC3 is not accessible to cytosolic protein kinase — To test for the cytosolic
exposure of the C-terminus, the PC3 construct with a C-terminal phosphorylation site (PC3-
p), wild-type PC3, and the corresponding oligoleucine-containing constructs (PC3-L19p and
PC3-L19) were expressed in COS-1 cells, labeled for 30 min with [32P]phosphate, and
analyzed by immunoprecipitation against the C1 epitope, SDS-gel electrophoresis, and
autoradiography. As a control, transfected cells were analyzed by Western blotting to reveal
steady-state levels of PC3 constructs in the cells. PC3 and PC3-p were not detectably labeled
with [32P]phosphate (Fig. 28, lanes 1 and 3). In contrast, PC3-L19p was strongly phosphory-
lated (lane 4), supporting a transmembrane disposition of the protein with the oligoleucine
segment as a transmembrane domain. Even PC3-L19 without the phosphorylation tag was
labeled (lane 2), indicating that the C-terminal region of PC3, which is rich in serines and
threonines, is unspecifically phosphorylated when exposed to the cytosol. These results thus
indicate that the C-terminus of PC3 is not exposed to the cytosol in intact cells.
FIG. 28.  PC3 is not phosphorylated at a C-terminal phosphorylation site.
Transfected COS-1 cells expressing PC3, PC3-L19, or the corresponding constructs PC3-p, or PC3-
L19p with a C-terminal site for phosphorylation by protein kinase A in the cytosol, were either labeled
for 30 min with [32P]phosphate ([32P]) and analyzed by immunoprecipitation, gel electrophoresis, and
autoradiography, or subjected to Western blot analysis (WB) as a measure of steady-state expression
levels. In parallel, mock-transfected cells were analyzed. Since generally the steady-state levels of PC3
and PC3-p were lower than those of the corresponding L19 constructs, three times more sample was
loaded in lanes 1 and 3. The positions of marker proteins with their molecular weights in kDa are
indicated.
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The C-terminus of PC3 is exposed to the ER lumen — N-Linked glycosylation is a luminal ER
modification frequently used to assay protein topology, since it provides positive evidence
for luminal localization of glycosylation sites. Human PC3 contains two potential sites for
N-glycosylation, both within the catalytic domain. Upon expression in COS-1 cells and
labeling for 30 min with [35S]methionine, a major species of the expected apparent molecular
weight of ~85 kDa was produced (Fig. 29, lane 4). This form corresponds to the processed
protein lacking the 83-residue pro-domain, which is autocatalytically removed. Deglycosyla-
tion of the protein by endoglycosidase H digestion results in a shift of ~3 kDa (lane 5),
indicating that PC3 is glycosylated at a single site. As a size marker, a truncation construct
lacking the signal sequence (PC3∆ss) was expressed in parallel (lanes 2 and 3). The resulting
uncleaved and unglycosylated pro-PC3, was larger than the deglycosylated PC3 product by
~8 kDa consistent with the size of the pro-domain.
PC3-g, due to the additional glycosylation tag, showed an electrophoretic mobility like
PC3∆ss (Fig. 29, lane 6). Deglycosylation generated twice the mobility shift observed for PC3
(lane 7), indicating that PC3-g was glycosylated twice: in the catalytic domain and in the
C-terminal extension. The C-terminus of PC3 is thus exposed to oligosaccharyl transferase in
the ER lumen, contradicting a transmembrane topology. Expression of PC3-L19 and PC3-
L19g generated two products each, with and without the pro-domain (Fig. 29, lane 8 and 10).
Upon deglycosylation, all forms shifted by only ~3 kDa, indicating a single glycosylation.
The additional glycosylation site at the C-terminus of PC3-L19g was therefore not translo-
cated into the ER lumen, consistent with a type I membrane-spanning topology.
FIG. 29.  The C-terminus of PC3 is exposed to the ER lumen.
Transfected COS-1 cells expressing PC3, PC3-L19, or the corresponding constructs PC3-g, or PC3-L19g
with an additional site of N-glycosylation at the C-terminus were labeled with [35S]methionine for 30
min and subjected to immunoprecipitation. The immunoprecipitates were split in half and incubated
with (+) or without (–) endoglycosidase H (EndoH) before gel electrophoresis and autoradiography.
In parallel, untransfected cells (–) were analyzed and cells transfected with PC3∆ss lacking the signal
sequence, as a size marker. Asterisks indicate background bands. Mobility shifts due to deglycosyla-
tion are indicated by lines. The positions of marker proteins with their molecular weights in kDa are
indicated.
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PC3 is protected from exogenous protease by the ER membrane — An alternative method to assay
for cytosolic protein domains is protease protection. Using isolated secretory granules, the
86 kDa form of PC3 was previously found to be sensitive to trypsin digestion (Arnaoutova et
al., 2003b). We applied this method to PC3 while still in the ER. Transfected COS-1 cells were
labeled for 30 min with [35S]methionine, swollen, and scraped to break the plasma mem-
brane. The permeabilized cells were then incubated with or without trypsin, or with trypsin
and detergent before immunoprecipitation and analysis. H1, which was analyzed as a
control, was resistant to trypsin digestion except for its N-terminal cytoplasmic domain of 40
amino acids (Fig. 30, lanes 7–9). PC3 was completely protected from hydrolysis, except when
the membrane was dissolved with detergent (lanes 1–3). In contrast, PC3-L19 disappeared
upon trypsin treatment, indicating that the C-terminal epitope was exposed on the outside of
the microsomal membranes. The results support the conclusion that PC3 resides entirely
within the ER lumen.
FIG. 30.  The C-terminus of PC3 is protected from protease digestion by the ER membrane.
Transfected COS-1 cells expressing PC3, PC3-L19, or the control protein H1 were labeled with
[35S]methionine for 30 min, broken by swelling and scraping and incubated on ice with or without
trypsin (T) or detergent (D). After addition of trypsin inhibitor, samples were lyzed, immuno-
precipitated, and analyzed by gel electrophoresis and autoradiography. An unspecific background
band is indicated by an asterisk. The positions of marker proteins with their molecular weights in kDa
are indicated.
The proposed transmembrane segments of PC3 and CPE do not function as stop-transfer sequences —
We previously created a stop-transfer tester construct, STT, on the basis of sequences of H1
(Fig. 26B) (Wessels and Spiess, 1988; Spiess et al., 1989). It consists of the N-terminal cytosolic
domain, the internal signal-anchor sequence, and a partially duplicated C-terminal domain
of H1 with 4 sites for N-linked glycosylation. The signal-anchor targets the protein to the ER
and induces translocation of the C-terminal domain. Upon expression in COS-1 cells and
[35S]methionine-labeling, STT is found as a major species with four glycans and a minor one
with three (Fig. 31, lanes 1–4). This is verified by partial deglycosylation with endoglycosi-
dase H, yielding a ladder of intermediates corresponding to polypeptides with 0–4
N-glycans. Sequences inserted between the second and the third glycosylation site can be
tested for their ability to stop further translocation of the polypeptide. If they do, like in the
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case of a second copy of the signal-anchor of H1 in STT-H138–65 (lanes 5–8), maximally two
glycosylation sites will reach the ER lumen. As observed previously (Wessels and Spiess,
1988), the resulting protein is glycosylated only once, because the second site is too close to
the second transmembrane segment.
In the construct STT-PC3599–657, the proposed transmembrane domain of PC3 together with
approximately 20 flanking residues on both sides was inserted into STT. When expressed in
COS-1 cells, the products were glycosylated three- and fourfold (Fig. 31, lanes 9–12), just like
STT without insertion. Similarly, the C-terminal 68 residues of CPE, including the segment of
residues 457–471 that had been implicated to span the membrane, produced three- and
fourfold glycosylation (lanes 13–16). The results indicate that both sequences cannot stop
protein transfer in the ER. In summary, the results demonstrate that PC3 is not a type I
membrane protein and that the proposed transmembrane segments of PC3 and CPE are not
functional as stop-transfer sequences in the ER.
FIG. 31.  The proposed transmembrane segments of PC3 and CPE do not stop polypeptide transloca-
tion in the ER.
Transfected COS-1 cells expressing the stop-transfer tester (STT) constructs without insertion, with the
signal-anchor sequence of H1, with residues 599–657 of PC3, or residues 409–470 of CPE were labeled
with [35S]methionine for 30 min and subjected to immunoprecipitation. Aliquots of the immunopre-
cipitates were incubated with 0 (–), 0.2 mU (+), or 5 mU (++) of endoglycosidase H (EndoH), and
analyzed by gel electrophoresis and autoradiography.
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Discussion
Because PC2, PC3, and CPE lack a conventional hydrophobic segment in their sequence, they
were initially considered to belong to the class of secretory proteins. All three proteins were
found, however, to associate with membranes, particularly with lipid rafts, a feature that was
proposed to mediate their sorting into secretory granules (Fricker, 1988a; Blazquez et al.,
2000; Dhanvantari and Loh, 2000; Blazquez et al., 2001). Membrane association thus qualified
them for classification as peripheral membrane proteins. The proposal that these three
proteins are integral membrane proteins spanning the lipid bilayer (Dhanvantari et al., 2002;
Arnaoutova et al., 2003b; Assadi et al., 2004) challenged this conventional model as well as
the traditional concepts on the properties of transmembrane segments.
Secretion of PC2, PC3, or CPE activity into the medium is mainly attributed to forms cleaved
at the end of the P-domain, releasing functional protein without its putative membrane
anchor. In the case of PC3, however, secretion of a 85-kDa form that includes its C-terminal
portion has been observed in the medium of cultured cells (Zhou et al., 1995; Boudreault et
al., 1998). This indicated that at least a fraction of PC3 is not spanning the membrane. This
leaves the possibility of partial anchoring of the polypeptide by an inefficient stop-transfer
sequence. An example where partial transmembrane insertion was observed is the prion
protein (Hegde et al., 1998; Hegde and Rane, 2003). It is normally synthesized with an
N-terminal cleaved signal and a C-terminal glycosyl phosphatidylinositol attachment
sequence as a translocated form called SecPrP. A fraction of the proteins, however, inserts into
the bilayer via an internal segment to produce the membrane-spanning forms NtmPrP and
CtmPrP. The transmembrane segment is mildly hydrophobic, which explains its behavior as
an "inefficient" stop-transfer sequence in a conventional way. In artificial proteins, the
minimal hydrophobicity to stop polypeptide translocation was found to correspond to a
stretch of 19 alanines or 9 leucines (Kuroiwa et al., 1991).
The proposed transmembrane domains of PC2, PC3, and CPE violate the rule that polypep-
tides crossing the hydrophobic core of the membrane have to be predominantly apolar. As
an explanation, it has been put forward that at acidic pH, as in the TGN or secretory
granules, glutamic and aspartic acid residues are partially protonated, and that within the
lipid bilayer the pKa may dramatically increase (Dhanvantari et al., 2002). Yet, the energy for
increasing the pKa by one pH unit calculated according to the formula ∆G° = RT·2.303·∆pKa
amounts to ~5.7 kJ/mol. This may be compensated by the transfer of neighboring apolar
residues into the hydrophobic environment of the bilayer. In the proposed transmembrane
segments, potentially charged residues outnumber hydrophobic residues by far. In addition,
even for the transfer of protonated acidic side chains into an apolar environment, the energy
for removing hydration water must be accounted for. Energetically, insertion of the pro-
posed sequences into the bilayer thus appears highly unfavorable.
In the case of PC3, spontaneous membrane insertion in an acidic organelle can be excluded,
because the translocation of 115 residues would have to be accomplished. For this reason, it
was suggested that the transmembrane orientation of PC3 is established during synthesis as
the protein enters the rough ER (Arnaoutova et al., 2003b). The proposed transmembrane
sequence, upon interacting with the ER membrane, would stop further translocation of the
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remainder of the C-terminal domain, which would stay on the cytosolic side of the mem-
brane. This is what we have experimentally tested in the present study. We have used COS-1
cells as a convenient cell system. The machinery for membrane integration in the ER is
unlikely to differ between cell types. Indeed, PC3 and PC3-g expressed in Neuro2a cells, a
neuroendocrine cell line, behaved exactly as in COS-1 cells (shown in the supplementary
material, Fig. 32). In our experiments, we found PC3 to be released from membranes upon
alkaline extraction (Fig. 27), an empirical method to distinguish integral membrane proteins
form peripheral or secretory proteins. We could not detect any phosphorylation of a
C-terminal target sequence of protein kinase A (Fig. 28), but efficient glycosylation of a
C-terminally attached glycosylation site (Fig. 29). The protein was furthermore resistant to
protease digestion in permeabilized cells (Fig. 30). The proposed transmembrane segment
and its flanking sequences also scored negative as part of a construct designed to test for
stop-transfer activity (Fig. 31). In all tests, PC3 behaved as expected for a completely
translocated protein, whereas PC3 with an inserted Leu19 sequence showed all the hallmarks
of a type I integral membrane protein. The results lead to the conclusion that neither segment
619–638 nor any other sequence in PC3 spans the lipid bilayer in a significant fraction of the
molecules.
The simplest explanation to rationalize the discrepancies between our experiments and those
described by Arnaoutova et al. (Arnaoutova et al., 2003b) is contamination of secretory
granules by PC3, in particular the 85-kDa form, from broken ER or Golgi during granule
purification. This material might be peripherally bound to the outside of the granule
membrane and account for antibody binding, biotinylation, and protease sensitivity. In
contrast, the phosphorylation and glycosylation assays used here reflect the situation in
intact, living cells. For protease protection, the cells' plasma membrane was broken by
swelling and scraping without further treatment before incubation with or without trypsin.
The conclusion that PC3 is not a membrane-spanning protein has implications on potential
sorting mechanisms of the protein, since direct interaction with cytosolic factors can be
excluded. Interaction with lipid rafts and/or raft-associated components is limited to the
exoplasmic surface of the TGN and granule membranes. With respect to the proposed
transmembrane segment of CPE, our stop-transfer test shows that it is not capable to halt
translocation of a polypeptide chain in the ER. Spontaneous integration in a later compart-
ment of the secretory pathway cannot be excluded from the data, but the energetics of
membrane integration do not make it seem likely. For polypeptide segments crossing the
lipid membrane, there is no convincing alternative to hydrophobic sequences, certainly not
in single-spanning proteins.
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Supplementary Material
Endocrine cells might have a different system for integrating polypeptides into the lipid
bilayer than fibroblast cells. All experiments in our publication (Stettler et al., 2005) were
performed in COS-1 cells since they provide a convenient cell system for studying protein
topology. To rule out the possibility that PC3 behaves differently in specialized cells, the
glycosylation assay (Fig. 29) was repeated in Neuro2a cells (Fig. 32).
Upon expression of PC3 Neuro2a and labeling with [35S]methionine a band was observed at
the expected apparent molecular weight of ~85 kDa (Fig. 32, lane 1) representing PC3
without prodomain. Endoglycosidase H treatment resulted in a size shift of ~3kDa (lane 2),
indicating that PC3 was glycosylated at a single site, most likely at one of the two potential
glycosylation sites within the catalytic domain. PC3-g was larger than PC3 due to its
additional glycosylation tag (lane 3). Upon treatment with endoglycosidase H, a mobility
shift of ~6 kDa was observed (lane 4) indicating that PC3-g is glycosylated twice, at an
internal site and at the C-terminus. The C-terminus is therefore exposed to the ER lumen and
accessible to the oligosaccharyl transferase as previously observed in COS-1 cells (Fig. 29).
PC3-L19 and PC3-L19g were glycosylated at a single site only (lanes 6-9) indicating that the
C-terminal glycosylation site of PC3-L19g was not translocated into the ER lumen, as
expected for a type I membrane-spanning protein.
In summary, PC3 and PC3-g behaved in Neuro2a exactly as in COS-1 cells. Therefore, it can
be ruled out that PC3 adopts a different topology in (neuro)endocrine cells than in non-
endocrine cells.
FIG. 32.  The C-terminus of PC3 is exposed to the ER lumen.
Transfected Neuro2a cells expressing PC3, PC3-L19, or the corresponding constructs PC3-g, or PC3-
L19g with an additional site of N-glycosylation at the C-terminus were labeled with [35S]methionine
for 30 min and subjected to immunoprecipitation. The immunoprecipitates were split in half and
incubated with (+) or without (–) endoglycosidase H (EndoH) before gel electrophoresis and autora-
diography. In parallel, untransfected cells were analyzed. Asterisks indicate background bands.
Mobility shifts due to deglycosylation are indicated by lines. The positions of marker proteins with
their molecular weights in kDa are indicated.
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GENERAL CONCLUSIONS
The formation of secretory granules has long been considered an endocrine-specific process.
Although it is not clear what the molecular players for segregation of regulated secretory
cargo and the subsequent formation of secretory granules are, it has generally been accepted
that the necessary machinery is exclusively present in specialized cells. Interestingly, when
we expressed regulated secretory proteins in fibroblast cell lines, we observed discrete
structures in the cell periphery. Regulated cargo proteins that were able to induce granule-
like structures include prohormones (pro-vasopressin, pro-oxytocin, and POMC), granins
(CgB and SgII) and the prohormone convertase PC3. Among these tested proteins, granins
were most efficient. Furthermore, granins played a supportive effect in sorting hormones
into granule-like structures and had an influence on the granule morphology when coex-
pressed. These findings clearly underline the helper role of granins. In ongoing studies, we
have analyzed the sorting of CgA into granule-like structures. Interestingly, N-terminal
truncation mutants of CgA that were constitutively secreted form neuroendocrine PC12 cells
(Taupenot et al., 2002) did not induce granule-like structures in COS-1 cells, and they could
not be redirected into granule-like structures when SgII was coexpressed. These data indicate
that the protein segments required for sorting into the regulated pathway of PC12 cells are
important for self-aggregation and co-aggregation with SgII.
When SgII was expressed in COS-1 cells, the IP3-R/Ca2+ channel was sorted into granule-
like. The IP3-R/Ca2+ channel could possibly be recruited by direct interaction of its luminal
domain with SgII, as it was shown to be the case for CgA and CgB (Yoo et al., 2002), or it
enters by default due to its abundance in TGN membranes. IP3-R is the first protein of
neuroendocrine secretory granules which was shown to be recruited to granule-like struc-
tures. However, IP3-R is not exclusively localized on secretory granules, but it is also found
in the ER and the nucleus. Nevertheless, these findings imply that accessory proteins have
affinity to granins even if they are not capable of inducing granule-like structures them-
selves. Granins may build heteroaggregates with other regulated secretory cargo and escort
them into granule-like structures acting as a guide. Yet, it is not clear if pro-vasopressin can
also recruit the IP3-R into granule-like structures. Further experiments are under way.
Live-imaging of SgII-DsRed transfected COS-1 cells stimulated with the ionophore A23187
resulted in an undirected movement of granule-like structures in the cell (data not shown).
The structures did not move towards the plasma membrane nor was any fusion event
observed within 15 min after stimulation. Granule-like structures did not move in a directed
way but rather appeared to move back and forth staying more or less in place. It appeared
that granule-like structures do not have the necessary machinery for movement to the
plasma membrane and for fusion. It remains unclear if and how these structures do fuse with
the plasma membrane.
Video microscopic studies on CgB-GFP transiently expressed in Vero cells revealed intervals
of rapid directed movement of transport carriers leaving the TGN (Wacker et al., 1997).
Transport was shown to occur in a microtubule-dependent manner, but movement was
discontinuous and occurred in all directions sometimes even changing directions. For direct
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and fast transport to the plasma membrane secretory granules are dependent on endocrine-
specific machinery.
In the following section, the similarities and differences between granule-like structures and
real secretory granules of specialized cells are summarized.
Criteria underlining that granule-like structures resemble secretory granules:
• Proteins are highly concentrated as concluded from immunofluorescence signals.
• Dense cores were observed by electron and differential interference contrast micros-
copy as well as by density gradient centrifugation (not shown).
• Electron microscopic analysis showed that membrane-bounded structures form at the
TGN.
• Immunofluorescence microscopy showed that granule-like structures do not co-
localize with markers for endosomes and lysosomes.
• Coexpressed cargo proteins sorted together into granule-like structures.
• Cargo proteins were segregated from a constitutively secreted marker protein.
• Biochemical storage of regulated secretory proteins was observed in pulse-chase
experiments.
• Stimulated release of regulated secretory proteins was triggered by ionophore.
• Granins played a helper role in sorting prohormones and influenced the morphology
of granule-like structures.
• Prohormone convertases PC3 and PC6A sorted into granule-like structures when
coexpressed with SgII.
• The IP3-R/Ca2+ channel was detected on the membranes of granule-like structures.
• Sorting of CgA mutants into PC12 secretory granules correlates with the formation of
granule-like structures in COS-1.
Criteria demonstrating that granule-like structures differ from secretory granules:
• Granule-like structures are larger than secretory granules.
• Precursor proteins are not processed because the appropriate enzymes are not ex-
pressed.
• Prohormone convertase PC2 was not sorted into granule-like structures when coex-
pressed with SgII.
• Intracellular storage varied from hardly detectable levels for pro-vasopressin to
above 70% for SgII.
• Storage in HEK293 cells was very inefficient.
• Stimulated secretion was inefficient and slow.
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• Live-imaging showed that granule-like structures were not efficiently transported to
the cell periphery.
• Fusion with the plasma membrane was not observed in stimulated cells.
Non-endocrine cells provide a convenient system to study the role and effects of individual
secretory proteins in isolation. In the future, additional factors (e.g. proteins involved in
transport, docking and fusion) could be tested for their potency to enhance the functionality
of granule-like structures.
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